Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ross J. Baldessarini, D.SC., M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R03MH073579 (BALDESSARINI, ROSS J) Jan 1, 2006 - May 30, 2008
    NIH/NIMH
    Antidepressant discontinuation effects
    Role: Principal Investigator
  2. R03MH073049 (BALDESSARINI, ROSS J) Aug 1, 2005 - Jul 31, 2007
    NIH/NIMH
    Course and Morbidity in Bipolar I Disorder
    Role: Principal Investigator
  3. K05MH047370 (BALDESSARINI, ROSS J) Jul 1, 1980 - Jun 30, 2001
    NIH/NIMH
    SYNAPTIC TRANSMISSION IN THE CENTRAL NERVOUS SYSTEMS
    Role: Principal Investigator
  4. R01MH034006 (BALDESSARINI, ROSS J) Apr 1, 1980 - Nov 30, 2000
    NIH/NIMH
    PHARMACOLOGY OF DOPAMINE RECEPTORS IN MAMMALIAN BRAIN
    Role: Principal Investigator
  5. S07RR005484 (COLE, JONATHAN O) Apr 1, 1979 - Sep 29, 1992
    NIH/NCRR
    COURSE OF DYSKINESIA
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Serra G, Koukopoulos A, De Chiara L, Koukopoulos AE, Sani G, Tondo L, Girardi P, Reginaldi D, Baldessarini RJ. Early clinical predictors of long-term morbidity in major depressive disorder. Early Interv Psychiatry. 2018 Dec 03. PMID: 30511367.
    View in: PubMed
  2. Pinna M, Visioli C, Rago CM, Manchia M, Tondo L, Baldessarini RJ. Attention deficit-hyperactivity disorder in adult bipolar disorder patients. J Affect Disord. 2019 01 15; 243:391-396. PMID: 30267955.
    View in: PubMed
  3. Pompili M, Lionetto L, Curto M, Forte A, Erbuto D, Montebovi F, Seretti ME, Berardelli I, Serafini G, Innamorati M, Amore M, Baldessarini RJ, Girardi P, Simmaco M. Tryptophan and Kynurenine Metabolites: Are They Related to Depression? Neuropsychobiology. 2019; 77(1):23-28. PMID: 30110684.
    View in: PubMed
  4. Khalsa HK, Baldessarini RJ, Tohen M, Salvatore P. Aggression among 216 patients with a first-psychotic episode of bipolar I disorder. Int J Bipolar Disord. 2018 Aug 11; 6(1):18. PMID: 30097737.
    View in: PubMed
  5. Curto M, Pompili E, Silvestrini C, Bellizzi P, Navari S, Pompili P, Manzi A, Bianchini V, Carlone C, Ferracuti S, Nicolò G, Baldessarini RJ. A novel SCL-90-R six-item factor identifies subjects at risk of early adverse outcomes in public mental health settings. Psychiatry Res. 2018 09; 267:376-381. PMID: 29957556.
    View in: PubMed
  6. Tondo L, Vázquez GH, Pinna M, Vaccotto PA, Baldessarini RJ. Characteristics of depressive and bipolar disorder patients with mixed features. Acta Psychiatr Scand. 2018 Sep; 138(3):243-252. PMID: 29862493.
    View in: PubMed
  7. Stefatos A, Ha JN, Baranchuk A, Baldessarini RJ, Vázquez GH. Atrial Fibrillation and Injected Aripiprazole: A Case Report. Innov Clin Neurosci. 2018 Jun 01; 15(5-6):43-45. PMID: 30013819.
    View in: PubMed
  8. Baldessarini RJ, Tondo L, Vázquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry. 2018 Apr 20. PMID: 29679069.
    View in: PubMed
  9. Tondo L, Baldessarini RJ. Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium? Pharmacopsychiatry. 2018 Sep; 51(5):177-188. PMID: 29672801.
    View in: PubMed
  10. Patel N, Viguera AC, Baldessarini RJ. Mood-Stabilizing Anticonvulsants, Spina Bifida, and Folate Supplementation: Commentary. J Clin Psychopharmacol. 2018 Feb; 38(1):7-10. PMID: 29215383.
    View in: PubMed
  11. Tondo L, Vázquez GH, Sani G, Pinna M, Baldessarini RJ. Association of suicidal risk with ratings of affective temperaments. J Affect Disord. 2018 03 15; 229:322-327. PMID: 29329066.
    View in: PubMed
  12. Sullivan K, Pantazopoulos H, Liebson E, Woo TW, Baldessarini RJ, Hedreen J, Berretta S. What can we learn about brain donors? Use of clinical information in human postmortem brain research. Handb Clin Neurol. 2018; 150:181-196. PMID: 29496141.
    View in: PubMed
  13. Vázquez GH, Gonda X, Lolich M, Tondo L, Baldessarini RJ. Suicidal Risk and Affective Temperaments, Evaluated with the TEMPS-A Scale: A Systematic Review. Harv Rev Psychiatry. 2018 Jan/Feb; 26(1):8-18. PMID: 29303918.
    View in: PubMed
  14. Marangoni C, Faedda GL, Baldessarini RJ. Clinical and Environmental Risk Factors for Bipolar Disorder: Review of Prospective Studies. Harv Rev Psychiatry. 2018 Jan/Feb; 26(1):1-7. PMID: 29303917.
    View in: PubMed
  15. Undurraga J, Baldessarini RJ. Tricyclic and selective serotonin-reuptake-inhibitor antidepressants compared with placebo in randomized trials for acute major depression. J Psychopharmacol. 2017 12; 31(12):1624-1625. PMID: 29182075.
    View in: PubMed
  16. Pompili M, Baldessarini RJ, Innamorati M, Vázquez GH, Rihmer Z, Gonda X, Forte A, Lamis DA, Erbuto D, Serafini G, Fiorillo A, Amore M, Girardi P. Corrigendum to "Temperaments in psychotic and major affective disorders" [J. Affect. Disord. (2018) 195-200]. J Affect Disord. 2018 08 15; 236:315. PMID: 29102381.
    View in: PubMed
  17. Khalsa HK, Denes AC, M Pasini-Hill D, Santelli JC, Baldessarini RJ. Specialized Police-Based Mental Health Crisis Response: The First 10 Years of Colorado's Crisis Intervention Team Implementation. Psychiatr Serv. 2018 Feb 01; 69(2):239-241. PMID: 29089008.
    View in: PubMed
  18. Giupponi G, Innamorati M, Baldessarini RJ, De Leo D, de Giovannelli F, Pycha R, Conca A, Girardi P, Pompili M. Factors associated with suicide: Case-control study in South Tyrol. Compr Psychiatry. 2018 01; 80:150-154. PMID: 29091781.
    View in: PubMed
  19. Pompili M, Verzura C, Trovini G, Buscajoni A, Falcone G, Naim S, Nardella A, Sorice S, Baldessarini RJ, Girardi P. Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders. Expert Opin Drug Saf. 2018 Feb; 17(2):197-205. PMID: 28902525.
    View in: PubMed
  20. Vázquez GH, Lolich M, Cabrera C, Jokic R, Kolar D, Tondo L, Baldessarini RJ. Mixed symptoms in major depressive and bipolar disorders: A systematic review. J Affect Disord. 2018 01 01; 225:756-760. PMID: 28922738.
    View in: PubMed
  21. Pompili M, Baldessarini RJ, Innamorati M, Vázquez GH, Rihmer Z, Gonda X, Forte A, Lamis DA, Erbuto D, Serafini G, Fiorillo A, Amore M, Girardi P. Temperaments in psychotic and major affective disorders. J Affect Disord. 2018 01 01; 225:195-200. PMID: 28837953.
    View in: PubMed
  22. De Crescenzo F, Serra G, Maisto F, Uchida M, Woodworth H, Casini MP, Baldessarini RJ, Vicari S. Suicide Attempts in Juvenile Bipolar Versus Major Depressive Disorders: Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017 Oct; 56(10):825-831.e3. PMID: 28942804.
    View in: PubMed
  23. Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, Calkin CV, Chillotti C, Hidalgo-Mazzei D, Manchia M, Müller-Oerlinghausen B, Murru A, Perugi G, Pinna M, Quaranta G, Reginaldi D, Reif A, Ritter P, Rybakowski JK, Saiger D, Sani G, Selle V, Stamm T, Vázquez GH, Veeh J, Vieta E, Baldessarini RJ. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord. 2017 Dec; 5(1):27. PMID: 28480485.
    View in: PubMed
  24. Baethge C, Tondo L, Baldessarini RJ. Methodological considerations regarding Joyce et al. 2016. Int J Bipolar Disord. 2017 Dec; 5(1):12. PMID: 28332119.
    View in: PubMed
  25. Undurraga J, Baldessarini RJ. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. J Psychopharmacol. 2017 09; 31(9):1184-1189. PMID: 28633600.
    View in: PubMed
  26. Baldessarini RJ, Tondo L. International suicide rates versus adequate treatments. Br J Psychiatry. 2017 04; 210(4):298-299. PMID: 28373225.
    View in: PubMed
  27. Tondo L, Vázquez GH, Baldessarini RJ. Depression and Mania in Bipolar Disorder. Curr Neuropharmacol. 2017 04; 15(3):353-358. PMID: 28503106.
    View in: PubMed
  28. Rajaratnam K, Xiang YT, Tripathi A, Chiu HF, Si TM, Chee KY, Avasthi A, Grover S, Chong MY, Kuga H, Kanba S, He YL, Lee MS, Yang SY, Udomratn P, Kallivayalil RA, Tanra AJ, Maramis MM, Shen WW, Sartorius N, Kua EH, Tan CH, Mahendran R, Shinfuku N, Sum MY, Baldessarini RJ, Sim K. Clinical Use of Mood Stabilizers With Antidepressants in Asia: Report From the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Projects in 2004 and 2013. J Clin Psychopharmacol. 2017 Apr; 37(2):255-259. PMID: 28146001.
    View in: PubMed
  29. Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K. Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II. Int J Neuropsychopharmacol. 2017 03 01; 20(3):281-284. PMID: 28003313.
    View in: PubMed
  30. Serra G, Koukopoulos A, De Chiara L, Koukopoulos AE, Sani G, Tondo L, Girardi P, Reginaldi D, Baldessarini RJ. Early clinical predictors and correlates of long-term morbidity in bipolar disorder. Eur Psychiatry. 2017 06; 43:35-43. PMID: 28365466.
    View in: PubMed
  31. Biagiarelli M, Curto M, Di Pomponio I, Comparelli A, Baldessarini RJ, Ferracuti S. Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment. Psychiatry Res. 2017 05; 251:294-297. PMID: 28236781.
    View in: PubMed
  32. Baldessarini RJ, Forte A, Selle V, Sim K, Tondo L, Undurraga J, Vázquez GH. Morbidity in Depressive Disorders. Psychother Psychosom. 2017; 86(2):65-72. PMID: 28183075.
    View in: PubMed
  33. Pompili M, Vichi M, Dinelli E, Erbuto D, Pycha R, Serafini G, Giordano G, Valera P, Albanese S, Lima A, De Vivo B, Cicchella D, Rihmer Z, Fiorillo A, Amore M, Girardi P, Baldessarini RJ. Arsenic: Association of regional concentrations in drinking water with suicide and natural causes of death in Italy. Psychiatry Res. 2017 03; 249:311-317. PMID: 28152464.
    View in: PubMed
  34. Vazquez GH, Camino S, Tondo L, Baldessarini RJ. Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics. CNS Neurol Disord Drug Targets. 2017; 16(8):858-869. PMID: 28758582.
    View in: PubMed
  35. Tondo L, Pinna M, Serra G, De Chiara L, Baldessarini RJ. Age at menarche predicts age at onset of major affective and anxiety disorders. Eur Psychiatry. 2017 01; 39:80-85. PMID: 27992810.
    View in: PubMed
  36. Baldessarini RJ, Innamorati M, Erbuto D, Serafini G, Fiorillo A, Amore M, Girardi P, Pompili M. Differential associations of affective temperaments and diagnosis of major affective disorders with suicidal behavior. J Affect Disord. 2017 03 01; 210:19-21. PMID: 27992854.
    View in: PubMed
  37. Rajaratnam K, Xiang YT, Tripathi A, Chiu HF, Si TM, Chee KY, Avasthi A, Grover S, Chong MY, Kuga H, Kanba S, He YL, Lee MS, Yang SY, Udomratn P, Kallivayalil RA, Tanra AJ, Maramis M, Shen WW, Sartorius N, Kua EH, Tan CH, Mahendran R, Shinfuku N, Sum MY, Baldessarini RJ, Sim K. Factors Associated With Antidepressant Dosing in Asia: Findings From the Research on Asian Psychotropic Prescription Study. J Clin Psychopharmacol. 2016 Dec; 36(6):716-719. PMID: 27753726.
    View in: PubMed
  38. Pompili M, Baldessarini RJ, Forte A, Erbuto D, Serafini G, Fiorillo A, Amore M, Girardi P. Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview. Int J Mol Sci. 2016 Oct 11; 17(10). PMID: 27727180.
    View in: PubMed
  39. Serra G, Koukopoulos A, De Chiara L, Napoletano F, Koukopoulos A, Sani G, Faedda GL, Girardi P, Reginaldi D, Baldessarini RJ. Child and Adolescent Clinical Features Preceding Adult Suicide Attempts. Arch Suicide Res. 2017 Jul 03; 21(3):502-518. PMID: 27673411.
    View in: PubMed
  40. Tondo L, Baldessarini RJ. Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment. Curr Psychiatry Rep. 2016 09; 18(9):88. PMID: 27542851.
    View in: PubMed
  41. Curto M, Girardi N, Lionetto L, Ciavarella GM, Ferracuti S, Baldessarini RJ. Systematic Review of Clozapine Cardiotoxicity. Curr Psychiatry Rep. 2016 07; 18(7):68. PMID: 27222142.
    View in: PubMed
  42. Tondo L, Vázquez GH, Baldessarini RJ. Depression and Mania in Bipolar Disorder. Curr Neuropharmacol. 2016 Jun 06. PMID: 27280739.
    View in: PubMed
  43. Tohen M, Khalsa HM, Salvatore P, Zarate CA, Strakowski SM, Sanchez-Toledo JP, Baldessarini RJ. The McLean-Harvard First-Episode Project: Early Course in 114 Cases of First-Episode Nonaffective Psychoses. J Clin Psychiatry. 2016 06; 77(6):781-8. PMID: 27232651.
    View in: PubMed
  44. Tondo L, Baldessarini RJ. Depression following mania. Mol Psychiatry. 2016 08; 21(8):990. PMID: 27113995.
    View in: PubMed
  45. Baldessarini RJ, Vázquez GH, Tondo L. Affective temperaments and suicidal ideation and behavior in mood and anxiety disorder patients. J Affect Disord. 2016 07 01; 198:78-82. PMID: 27011363.
    View in: PubMed
  46. Yanzón de la Torre A, Oliva N, Echevarrieta PL, Pérez BG, Caporusso GB, Titaro AJ, Todaro Kicyla A, Cuatz M, Locatelli M, Nelson LM, Mac Mullen M, Baldessarini RJ, Daray FM. Major depression in hospitalized Argentine general medical patients: Prevalence and risk factors. J Affect Disord. 2016 Jun; 197:36-42. PMID: 26967917.
    View in: PubMed
  47. Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP, Sim K. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016 Jan; 2(1):59-66. PMID: 27703755.
    View in: PubMed
  48. Arefian H, Hagel S, Heublein S, Rissner F, Scherag A, Brunkhorst FM, Baldessarini RJ, Hartmann M. Extra length of stay and costs because of health care-associated infections at a German university hospital. Am J Infect Control. 2016 Feb; 44(2):160-6. PMID: 26521700.
    View in: PubMed
  49. Baldessarini RJ, Tondo L, Visioli C, Vázquez GH. Illness history: Not associated with remission during treatment of major depression in 515 mood disorder patients. J Affect Disord. 2016 Feb; 191:118-22. PMID: 26655121.
    View in: PubMed
  50. Tondo L, Pompili M, Forte A, Baldessarini RJ. Suicide attempts in bipolar disorders: comprehensive review of 101 reports. Acta Psychiatr Scand. 2016 Mar; 133(3):174-86. PMID: 26555604.
    View in: PubMed
  51. Vöhringer PA, Ostacher MJ, El-Mallakh RS, Holtzman NS, Thommi SB, Whitham EA, Sullivan MC, Baldassano CF, Goodwin FK, Baldessarini RJ, Ghaemi SN. Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial. J Clin Psychopharmacol. 2015 Oct; 35(5):605-8. PMID: 26267418; PMCID: PMC4553065 [Available on 10/01/16].
  52. Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K. Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder. Int J Neuropsychopharmacol. 2015 Sep 13; 19(3):pyv107. PMID: 26371184.
    View in: PubMed
  53. Curto M, Comparelli A, Ciavarella GM, Gasperoni C, Lionetto L, Corigliano V, Uccellini A, Mancinelli I, Ferracuti S, Girardi P, Baldessarini RJ. Impairment of left ventricular function early in treatment with clozapine: a preliminary study. Int Clin Psychopharmacol. 2015 Sep; 30(5):282-9. PMID: 26049674.
    View in: PubMed
  54. Pompili M, Baldessarini RJ. Risk of suicide and all-cause mortality after self-harm. Lancet Psychiatry. 2015 Sep; 2(9):769-70. PMID: 26254718.
    View in: PubMed
  55. Pompili M, Vichi M, Dinelli E, Pycha R, Valera P, Albanese S, Lima A, De Vivo B, Cicchella D, Fiorillo A, Amore M, Girardi P, Baldessarini RJ. Relationships of local lithium concentrations in drinking water to regional suicide rates in Italy. World J Biol Psychiatry. 2015; 16(8):567-74. PMID: 26230215.
    View in: PubMed
  56. Vázquez GH, Holtzman JN, Lolich M, Ketter TA, Baldessarini RJ. Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials. Eur Neuropsychopharmacol. 2015 Oct; 25(10):1501-12. PMID: 26238969.
    View in: PubMed
  57. Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials. Int J Neuropsychopharmacol. 2015 Jul 07; 19(2). PMID: 26152228; PMCID: PMC4772815.
  58. Stoklosa J, Rose AB, Liebson ES, Goldblatt MJ, Baldessarini RJ. Intensely Suicidal Behavior with a First Manic Episode. Harv Rev Psychiatry. 2015 Jul-Aug; 23(4):288-95. PMID: 26146756.
    View in: PubMed
  59. Tondo L, Vázquez GH, Baethge C, Baronessa C, Bolzani L, Koukopoulos A, Mazzarini L, Murru A, Pacchiarotti I, Pinna M, Salvatore P, Sani G, Selle V, Spalletta G, Girardi P, Tohen M, Vieta E, Baldessarini RJ. Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study. Acta Psychiatr Scand. 2016 Jan; 133(1):34-43. PMID: 26096273.
    View in: PubMed
  60. Vázquez GH, Holtzman JN, Tondo L, Baldessarini RJ. Efficacy and tolerability of treatments for bipolar depression. J Affect Disord. 2015 Sep 01; 183:258-62. PMID: 26042634.
    View in: PubMed
  61. Viguera AC, Milano N, Laurel R, Thompson NR, Griffith SD, Baldessarini RJ, Katzan IL. Comparison of Electronic Screening for Suicidal Risk With the Patient Health Questionnaire Item 9 and the Columbia Suicide Severity Rating Scale in an Outpatient Psychiatric Clinic. Psychosomatics. 2015 Sep-Oct; 56(5):460-9. PMID: 26278339.
    View in: PubMed
  62. Faedda GL, Marangoni C, Serra G, Salvatore P, Sani G, Vázquez GH, Tondo L, Girardi P, Baldessarini RJ, Koukopoulos A. Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry. 2015 May; 76(5):614-24. PMID: 26035191.
    View in: PubMed
  63. Forte A, Baldessarini RJ, Tondo L, Vázquez GH, Pompili M, Girardi P. Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. J Affect Disord. 2015 Jun 01; 178:71-8. PMID: 25797049.
    View in: PubMed
  64. Balda MV, Garay OU, Papale RM, Bignone I, Bologna VG, Brandolini A, Prokopez CR, Balasini JI, Baldessarini RJ, Daray FM. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012). Int Clin Psychopharmacol. 2015 Mar; 30(2):109-14. PMID: 25486383.
    View in: PubMed
  65. Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K. Duration of initial antidepressant treatment and subsequent relapse of major depression. J Clin Psychopharmacol. 2015 Feb; 35(1):75-6. PMID: 25502491.
    View in: PubMed
  66. Ventriglio A, Gentile A, Baldessarini RJ, Bellomo A. Early-life stress and psychiatric disorders: epidemiology, neurobiology and innovative pharmacological targets. Curr Pharm Des. 2015; 21(11):1379-87. PMID: 25564392.
    View in: PubMed
  67. Serra G, Koukopoulos A, De Chiara L, Koukopoulos AE, Tondo L, Girardi P, Baldessarini RJ, Serra G. Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder. J Clin Psychiatry. 2015 Jan; 76(1):e91-7. PMID: 25650685.
    View in: PubMed
  68. Hui Poon S, Sim K, Baldessarini RJ. Pharmacological Approaches for Treatment-resistant Bipolar Disorder. Curr Neuropharmacol. 2015; 13(5):592-604. PMID: 26467409; PMCID: PMC4761631.
  69. Wingo AP, Baldessarini RJ, Windle M. Coping styles: longitudinal development from ages 17 to 33 and associations with psychiatric disorders. Psychiatry Res. 2015 Feb 28; 225(3):299-304. PMID: 25582968; PMCID: PMC4314401.
  70. Baldessarini RJ. Risks in discontinuation trials with antidepressants. J Clin Psychiatry. 2014 Dec; 75(12):e1443. PMID: 25551243.
    View in: PubMed
  71. Serra G, Koukopoulos A, De Chiara L, Napoletano F, Koukopoulos AE, Curto M, Manfredi G, Faedda G, Girardi P, Baldessarini RJ. Features preceding diagnosis of bipolar versus major depressive disorders. J Affect Disord. 2015 Mar 01; 173:134-42. PMID: 25462407.
    View in: PubMed
  72. Yildiz A, Vieta E, Correll CU, Nikodem M, Baldessarini RJ. Critical issues on the use of network meta-analysis in psychiatry. Harv Rev Psychiatry. 2014 Nov-Dec; 22(6):367-72. PMID: 25377612.
    View in: PubMed
  73. Camsari U, Viguera AC, Ralston L, Baldessarini RJ, Cohen LS. Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men. Arch Womens Ment Health. 2014 Dec; 17(6):583-6. PMID: 25253022.
    View in: PubMed
  74. Baldessarini RJ. The impact of psychopharmacology on contemporary psychiatry. Can J Psychiatry. 2014 Aug; 59(8):401-5. PMID: 25161063; PMCID: PMC4143295.
  75. Faedda GL, Serra G, Marangoni C, Salvatore P, Sani G, Vázquez GH, Tondo L, Girardi P, Baldessarini RJ, Koukopoulos A. Clinical risk factors for bipolar disorders: a systematic review of prospective studies. J Affect Disord. 2014 Oct; 168:314-21. PMID: 25086290.
    View in: PubMed
  76. Yildiz A, Nikodem M, Vieta E, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med. 2015 Jan; 45(2):299-317. PMID: 25036226.
    View in: PubMed
  77. Dickstein LP, Viguera AC, Nowacki AS, Thompson NR, Griffith SD, Baldessarini RJ, Katzan IL. Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center. Psychosomatics. 2015 Jan-Feb; 56(1):44-51. PMID: 25619673.
    View in: PubMed
  78. Tondo L, Visioli C, Preti A, Baldessarini RJ. Bipolar disorders following initial depression: modeling predictive clinical factors. J Affect Disord. 2014; 167:44-9. PMID: 25082113.
    View in: PubMed
  79. Baldessarini RJ, Tondo L. Are renal tumors associated with lithium treatment? Int J Bipolar Disord. 2014; 2:6. PMID: 25909049; PMCID: PMC4406981.
  80. Schalkwijk S, Undurraga J, Tondo L, Baldessarini RJ. Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. Int J Neuropsychopharmacol. 2014 Aug; 17(8):1343-52. PMID: 24621827.
    View in: PubMed
  81. Vázquez GH, Baldessarini RJ, Tondo L. Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview. Depress Anxiety. 2014 Mar; 31(3):196-206. PMID: 24610817.
    View in: PubMed
  82. Selle V, Schalkwijk S, Vázquez GH, Baldessarini RJ. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry. 2014 Mar; 47(2):43-52. PMID: 24549862.
    View in: PubMed
  83. Salvatore P, Bhuvaneswar C, Tohen M, Khalsa HM, Maggini C, Baldessarini RJ. Capgras' syndrome in first-episode psychotic disorders. Psychopathology. 2014; 47(4):261-9. PMID: 24516070; PMCID: PMC4065173.
  84. Tondo L, Vázquez GH, Baldessarini RJ. Options for pharmacological treatment of refractory bipolar depression. Curr Psychiatry Rep. 2014 Feb; 16(2):431. PMID: 24425269.
    View in: PubMed
  85. Ventriglio A, Gentile A, Baldessarini RJ, Martone S, Vitrani G, La Marca A, Bellomo A. Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients. Eur Psychiatry. 2014 Sep; 29(7):402-7. PMID: 24439513.
    View in: PubMed
  86. Masters GA, Baldessarini RJ, Öngür D, Centorrino F. Factors associated with length of psychiatric hospitalization. Compr Psychiatry. 2014 Apr; 55(3):681-7. PMID: 24387922.
    View in: PubMed
  87. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62. PMID: 24030475.
    View in: PubMed
  88. Baldessarini RJ, Tondo L, Visioli C. First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand. 2014 May; 129(5):383-92. PMID: 24152091.
    View in: PubMed
  89. Reginaldi D, Koukopoulos A, Baldessarini RJ, Faedda GL, Fazzari G, Girardi P, Kotzalidis G, Manfredi G, Minnai GP, Pacchiarotti I, Raja M, Sani G, Serra G, Tondo L, Vieta E. Transitions: Athanasios Koukopoulos [A?a??s??? ?????p?????], M.D. (1931-2013). Int J Bipolar Disord. 2013 Dec; 1(1):18. PMID: 26054599; PMCID: PMC4406978.
  90. Tondo L, Baldessarini RJ. Fertility rates in patients with mood disorder in Sweden and Sardinia. JAMA Psychiatry. 2013 Oct; 70(10):1115. PMID: 24089037.
    View in: PubMed
  91. Baldessarini R, Selle V, Vigo DV. [Enduring pain II. Treatment]. Vertex. 2013 Sep-Oct; 24(111):351-8. PMID: 24312919.
    View in: PubMed
  92. Vigo DV, Selle V, Baldessarini R. [Enduring pain I. Nosology and epidemiology]. Vertex. 2013 Sep-Oct; 24(111):345-50. PMID: 24312918.
    View in: PubMed
  93. Salvatore P, Baldessarini RJ, Khalsa HM, Indic P, Maggini C, Tohen M. Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal Risk. J Depress Anxiety. 2013 Jul 27; 2. PMID: 24288656.
    View in: PubMed
  94. Salvatore P, Baldessarini RJ, Khalsa HM, Vázquez G, Perez J, Faedda GL, Amore M, Maggini C, Tohen M. Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients. Acta Psychiatr Scand. 2014 Apr; 129(4):275-85. PMID: 23837831; PMCID: PMC3797176.
  95. Koukopoulos A, Reginaldi D, Tondo L, Visioli C, Baldessarini RJ. Course sequences in bipolar disorder: depressions preceding or following manias or hypomanias. J Affect Disord. 2013 Oct; 151(1):105-10. PMID: 23827534.
    View in: PubMed
  96. Salvatore P, Baldessarini RJ, Khalsa HM, Amore M, Di Vittorio C, Ferraro G, Maggini C, Tohen M. Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features. J Clin Psychiatry. 2013 Jul; 74(7):723-31; quiz 731. PMID: 23945450.
    View in: PubMed
  97. Ventriglio A, Baldessarini RJ, Iuso S, La Torre A, D'Onghia A, La Salandra M, Mazza M, Bellomo A. Language proficiency among hospitalized immigrant psychiatric patients in Italy. Int J Soc Psychiatry. 2014 May; 60(3):299-303. PMID: 23741004.
    View in: PubMed
  98. Pagel T, Baldessarini RJ, Franklin J, Baethge C. Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder. Bipolar Disord. 2013 May; 15(3):229-39. PMID: 23528024.
    View in: PubMed
  99. Baethge C, Assall OP, Baldessarini RJ. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom. 2013; 82(3):152-60. PMID: 23548796.
    View in: PubMed
  100. Offidani E, Fava GA, Tomba E, Baldessarini RJ. Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom. 2013; 82(3):132-41. PMID: 23548764.
    View in: PubMed
  101. Ye N, Neumeyer JL, Baldessarini RJ, Zhen X, Zhang A. Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev. 2013 May 08; 113(5):PR123-78. PMID: 23464812.
    View in: PubMed
  102. Pagel T, Baldessarini RJ, Franklin J, Baethge C. Heterogeneity of schizoaffective disorder compared with schizophrenia and bipolar disorder. Acta Psychiatr Scand. 2013 Oct; 128(4):238-50. PMID: 23465195.
    View in: PubMed
  103. Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol. 2013 Aug; 16(7):1673-85. PMID: 23428003.
    View in: PubMed
  104. Pérez J, Girón-Irueste F, Gurpegui M, Baldessarini RJ, de Leon J. The lions of Granada Maristan. Am J Psychiatry. 2013 Feb; 170(2):152-3. PMID: 23377635.
    View in: PubMed
  105. Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev. 2013 Mar; 37(3):418-35. PMID: 23318228.
    View in: PubMed
  106. Undurraga J, Tondo L, Schalkwijk S, Vieta E, Baldessarini RJ. Re-analysis of the earliest controlled trials of imipramine. J Affect Disord. 2013 May; 147(1-3):451-4. PMID: 23246207.
    View in: PubMed
  107. Baldessarini RJ, Faedda GL, Offidani E, Vázquez GH, Marangoni C, Serra G, Tondo L. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord. 2013 May 15; 148(1):129-35. PMID: 23219059.
    View in: PubMed
  108. Baldessarini RJ. Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Saf. 2012 Dec 01; 35(12):1183; author reply 1183-4. PMID: 23137152.
    View in: PubMed
  109. Salvatore P, Indic P, Murray G, Baldessarini RJ. Biological rhythms and mood disorders. Dialogues Clin Neurosci. 2012 Dec; 14(4):369-79. PMID: 23393414; PMCID: PMC3553575.
  110. Pérez J, Baldessarini RJ, Undurraga J, Sánchez-Moreno J. Origins of psychiatric hospitalization in medieval Spain. Psychiatr Q. 2012 Dec; 83(4):419-30. PMID: 22350131.
    View in: PubMed
  111. Tondo L, Baldessarini RJ, Vázquez G, Lepri B, Visioli C. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatr Scand. 2013 May; 127(5):355-64. PMID: 23121222.
    View in: PubMed
  112. Centorrino F, Masters GA, Talamo A, Baldessarini RJ, Öngür D. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics. Hum Psychopharmacol. 2012 Sep; 27(5):521-6. PMID: 22996619.
    View in: PubMed
  113. Poon SH, Sim K, Sum MY, Kuswanto CN, Baldessarini RJ. Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disord. 2012 Sep; 14(6):573-84. PMID: 22938165.
    View in: PubMed
  114. Lorenzo LS, Vázquez GH, Zaratiegui RM, Tondo L, Baldessarini RJ. Characteristics of bipolar disorder patients given antidepressants. Hum Psychopharmacol. 2012 Sep; 27(5):486-91. PMID: 22927134.
    View in: PubMed
  115. Indic P, Murray G, Maggini C, Amore M, Meschi T, Borghi L, Baldessarini RJ, Salvatore P. Multi-scale motility amplitude associated with suicidal thoughts in major depression. PLoS One. 2012; 7(6):e38761. PMID: 22701706; PMCID: PMC3373552.
  116. Undurraga J, Baldessarini RJ, Valentí M, Pacchiarotti I, Tondo L, Vázquez G, Vieta E. Bipolar depression: clinical correlates of receiving antidepressants. J Affect Disord. 2012 Jun; 139(1):89-93. PMID: 22406337.
    View in: PubMed
  117. Baldessarini RJ, Tondo L, Vazquez GH, Undurraga J, Bolzani L, Yildiz A, Khalsa HM, Lai M, Lepri B, Lolich M, Maffei PM, Salvatore P, Faedda GL, Vieta E, Tohen M. Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry. 2012 Feb; 11(1):40-6. PMID: 22295008; PMCID: PMC3266753.
  118. Undurraga J, Baldessarini RJ, Valenti M, Pacchiarotti I, Vieta E. Suicidal risk factors in bipolar I and II disorder patients. J Clin Psychiatry. 2012 Jun; 73(6):778-82. PMID: 22225677.
    View in: PubMed
  119. Newport DJ, Baldessarini RJ, Knight BT, Fernandez SV, Morris NJ, Viguera AC, Stowe ZN. Comparison of women with confirmed versus presumably misdiagnosed bipolar disorder. J Clin Psychiatry. 2012 Feb; 73(2):242-6. PMID: 22225624.
    View in: PubMed
  120. Baldessarini RJ, Undurraga J, Vázquez GH, Tondo L, Salvatore P, Ha K, Khalsa HM, Lepri B, Ha TH, Chang JS, Tohen M, Vieta E. Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand. 2012 Apr; 125(4):293-302. PMID: 22188017.
    View in: PubMed
  121. Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology. 2012 Mar; 37(4):851-64. PMID: 22169941; PMCID: PMC3280655.
  122. Kelleher JP, Centorrino F, Huxley NA, Bates JA, Drake JK, Egli S, Baldessarini RJ. Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol. 2012 Jun; 22(6):415-8. PMID: 22153972.
    View in: PubMed
  123. Leiderman EA, Lolich M, Vázquez GH, Baldessarini RJ. Depression: point-prevalence and sociodemographic correlates in a Buenos Aires community sample. J Affect Disord. 2012 Feb; 136(3):1154-8. PMID: 22036799.
    View in: PubMed
  124. Baldessarini RJ, Salvatore P, Khalsa HK, Imaz-Etxeberria H, Gonzalez-Pinto A, Tohen M. Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J Affect Disord. 2012 Jan; 136(1-2):149-154. PMID: 21943930.
    View in: PubMed
  125. Tohen M, Khalsa HK, Salvatore P, Vieta E, Ravichandran C, Baldessarini RJ. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord. 2012 Jan; 136(1-2):1-8. PMID: 21943929.
    View in: PubMed
  126. Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, Baldessarini RJ. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry. 2011 Nov; 168(11):1179-85. PMID: 21799064.
    View in: PubMed
  127. Baldessarini RJ, Gardner DM. Incidence of extrapyramidal syndromes and tardive dyskinesia. J Clin Psychopharmacol. 2011 Jun; 31(3):382-4; author reply 384-5. PMID: 21532367.
    View in: PubMed
  128. Indic P, Salvatore P, Maggini C, Ghidini S, Ferraro G, Baldessarini RJ, Murray G. Scaling behavior of human locomotor activity amplitude: association with bipolar disorder. PLoS One. 2011; 6(5):e20650. PMID: 21655197; PMCID: PMC3105113.
  129. Baldessarini RJ. Suicidal risk during antidepressant treatment. J Clin Psychiatry. 2011 May; 72(5):722; author reply 722. PMID: 21658355.
    View in: PubMed
  130. Sim K, Yong KH, Chan YH, Tor PC, Xiang YT, Wang CY, Lee EH, Fujii S, Yang SY, Chong MY, Ungvari GS, Si T, He YL, Chung EK, Chee KY, Trivedi J, Udomratn P, Shinfuku N, Kua EH, Tan CH, Sartorius N, Baldessarini RJ. Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: Asia psychotropic prescription study (2001-2008). Int J Neuropsychopharmacol. 2011 Oct; 14(9):1157-64. PMID: 21557883.
    View in: PubMed
  131. Pompili M, Baldessarini RJ, Berman AL, Lester D, Wasserman D, De Leo D, Girardi P. Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns. 2011 Oct; 85(1):127-8. PMID: 21458193.
    View in: PubMed
  132. Baldessarini RJ. Commentary: the current state of psychopharmacology and psychiatry. Rev Psiquiatr Salud Ment. 2011 Jan; 4(1):5-8. PMID: 23446096.
    View in: PubMed
  133. Vázquez G, Baldessarini RJ, Yildiz A, Tamayo J, Tondo L, Salvatore P. Multisite international collaborative clinical trials in mania. Int J Neuropsychopharmacol. 2011 Sep; 14(8):1013-6. PMID: 21439104.
    View in: PubMed
  134. Baldessarini RJ, Vázquez G, Tondo L. Treatment of cyclothymic disorder: commentary. Psychother Psychosom. 2011; 80(3):131-5. PMID: 21372620.
    View in: PubMed
  135. Pérez J, Baldessarini RJ, Cruz N, Salvatore P, Vieta E. Andrés Piquer-Arrufat (1711-1772): contributions of an eighteenth-century spanish physician to the concept of manic-depressive illness. Harv Rev Psychiatry. 2011 Mar-Apr; 19(2):68-77. PMID: 21425935.
    View in: PubMed
  136. Ventriglio A, Vincenti A, Centorrino F, Talamo A, Fitzmaurice G, Baldessarini RJ. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients. Int Clin Psychopharmacol. 2011 Mar; 26(2):88-95. PMID: 21030870.
    View in: PubMed
  137. Yildiz A, Vieta E, Tohen M, Baldessarini RJ. Factors modifying drug and placebo responses in randomized trials for bipolar mania. Int J Neuropsychopharmacol. 2011 Aug; 14(7):863-75. PMID: 21299919.
    View in: PubMed
  138. Tor PC, Ng TP, Yong KH, Sim K, Xiang YT, Wang CY, Lee EH, Fujii S, Yang SY, Chong MY, Ungvari GS, Si T, He YL, Chung EK, Chee KY, Trivedi J, Udomratn P, Shinfuku N, Kua EH, Tan CH, Sartorius N, Baldessarini RJ. Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008. Int J Neuropsychopharmacol. 2011 Jul; 14(6):735-45. PMID: 21294941.
    View in: PubMed
  139. Tondo L, Lepri B, Baldessarini RJ. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders. Acta Psychiatr Scand. 2011 Apr; 123(4):283-9. PMID: 21219264.
    View in: PubMed
  140. Tarsy D, Lungu C, Baldessarini RJ. Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. Handb Clin Neurol. 2011; 100:601-16. PMID: 21496610.
    View in: PubMed
  141. Pompili M, Baldessarini RJ. Epilepsy: Risk of suicidal behavior with antiepileptic drugs. Nat Rev Neurol. 2010 Dec; 6(12):651-3. PMID: 21131913.
    View in: PubMed
  142. Baldessarini RJ. Commentary: the Bipolar Affective Disorder: Lithium/Anticonvulsant Evaluation (BALANCE) study. Bipolar Disord. 2010 Nov; 12(7):669-72. PMID: 21066906.
    View in: PubMed
  143. Vázquez G, Tondo L, Baldessarini RJ. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. Pharmacopsychiatry. 2011 Jan; 44(1):21-6. PMID: 21031345.
    View in: PubMed
  144. Yildiz A, Vieta E, Leucht S, Baldessarini RJ. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology. 2011 Jan; 36(2):375-89. PMID: 20980991; PMCID: PMC3055677.
  145. Vincenti A, Ventriglio A, Baldessarini RJ, Talamo A, Fitzmaurice G, Centorrino F. Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders. Pharmacopsychiatry. 2010 Aug; 43(6):225-32. PMID: 20652858.
    View in: PubMed
  146. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA, Vieta E, Maggini C. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2011 Feb; 72(2):183-93. PMID: 20673546.
    View in: PubMed
  147. Harvey PD, Wingo AP, Burdick KE, Baldessarini RJ. Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord. 2010 Jun; 12(4):364-75. PMID: 20636633.
    View in: PubMed
  148. Baldessarini RJ, Tondo L, Ghiani C, Lepri B. Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry. 2010 Aug; 167(8):934-41. PMID: 20478876.
    View in: PubMed
  149. Wingo AP, Baldessarini RJ, Holtzheimer PE, Harvey PD. Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord. 2010 May; 12(3):319-26. PMID: 20565439; PMCID: PMC3749090.
  150. Baldessarini RJ, Salvatore P, Khalsa HM, Gebre-Medhin P, Imaz H, González-Pinto A, Perez J, Cruz N, Maggini C, Tohen M. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord. 2010 May; 12(3):264-70. PMID: 20565433.
    View in: PubMed
  151. Pompili M, Tatarelli R, Girardi P, Tondo L, Baldessarini RJ. Suicide risk during anticonvulsant treatment. Pharmacoepidemiol Drug Saf. 2010 May; 19(5):525-8. PMID: 20437459.
    View in: PubMed
  152. Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL. Bipolar depression: overview and commentary. Harv Rev Psychiatry. 2010 May-Jun; 18(3):143-57. PMID: 20415631.
    View in: PubMed
  153. Baldessarini RJ, Salvatore P, Khalsa HM, Tohen M. Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder. J Affect Disord. 2010 Oct; 126(1-2):299-302. PMID: 20427091; PMCID: PMC2925064.
  154. Baldessarini RJ, Viguera AC. Perinatal screening for depression. Am J Obstet Gynecol. 2010 Aug; 203(2):e16; author reply e17. PMID: 20417471.
    View in: PubMed
  155. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010 Jun; 167(6):686-93. PMID: 20360319.
    View in: PubMed
  156. Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010 Apr; 71(4):372-80. PMID: 20409444.
    View in: PubMed
  157. Wingo AP, Baldessarini RJ, Compton MT, Harvey PD. Correlates of recovery of social functioning in types I and II bipolar disorder patients. Psychiatry Res. 2010 May 15; 177(1-2):131-4. PMID: 20334933; PMCID: PMC2859974.
  158. Centorrino F, Ventriglio A, Vincenti A, Talamo A, Baldessarini RJ. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Hum Psychopharmacol. 2010 Mar; 25(2):179-86. PMID: 20196186.
    View in: PubMed
  159. Baldessarini RJ, Tondo L, Lepri B. Correlation of initial wellness with long-term morbidity in recurrent major affective disorder patients as a test of survival analysis. J Clin Psychopharmacol. 2010 Feb; 30(1):72-5. PMID: 20075652.
    View in: PubMed
  160. Girardi P, Serafini G, Pompili M, Innamorati M, Tatarelli R, Baldessarini RJ. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients. Pharmacopsychiatry. 2010 Mar; 43(2):66-72. PMID: 20099224.
    View in: PubMed
  161. Viguera AC, Cohen LS, Whitfield T, Reminick AM, Bromfield E, Baldessarini RJ. Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists. Arch Womens Ment Health. 2010 Apr; 13(2):175-8. PMID: 20049492.
    View in: PubMed
  162. Tondo L, Lepri B, Cruz N, Baldessarini RJ. Age at onset in 3014 Sardinian bipolar and major depressive disorder patients. Acta Psychiatr Scand. 2010 Jun; 121(6):446-52. PMID: 20040069.
    View in: PubMed
  163. Tondo L, Vázquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand. 2010 Jun; 121(6):404-14. PMID: 19958306.
    View in: PubMed
  164. Bhuvaneswar CG, Baldessarini RJ, Harsh VL, Alpert JE. Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review. CNS Drugs. 2009 Dec; 23(12):1003-21. PMID: 19958039.
    View in: PubMed
  165. Fawcett JA, Baldessarini RJ, Coryell WH, Silverman MM, Stein DJ. Definition and management of suicidality in psychiatric patients. J Clin Psychiatry. 2009 Oct; 70(10):e38. PMID: 19906337.
    View in: PubMed
  166. Pompili M, Baldessarini RJ, Tondo L, Innamorati M, Tatarelli R, Girardi P, De Pisa E. Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients. J Affect Disord. 2010 Apr; 122(1-2):154-8. PMID: 19709752.
    View in: PubMed
  167. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry. 2009 Nov; 70(11):1588-97. PMID: 19689922.
    View in: PubMed
  168. Baethge C, Tondo L, Lepri B, Baldessarini RJ. Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord. 2009 Aug; 11(5):494-503. PMID: 19624388.
    View in: PubMed
  169. Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc. 2009 Jul-Sep; 18(3):179-83. PMID: 20034193.
    View in: PubMed
  170. Baldessarini RJ, Bolzani L, Cruz N, Jones PB, Lai M, Lepri B, Perez J, Salvatore P, Tohen M, Tondo L, Vieta E. Onset-age of bipolar disorders at six international sites. J Affect Disord. 2010 Feb; 121(1-2):143-6. PMID: 19560827.
    View in: PubMed
  171. Fawcett JA, Baldessarini RJ, Coryell WH, Silverman MM, Stein DJ. Defining and managing suicidal risk in patients taking psychotropic medications. J Clin Psychiatry. 2009 Jun; 70(6):782-9. PMID: 19573477.
    View in: PubMed
  172. Baldessarini RJ. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009 May 14; 360(20):2136-7; author reply 2137-8. PMID: 19439751.
    View in: PubMed
  173. Girardi P, Pompili M, Innamorati M, Mancini M, Serafini G, Mazzarini L, Del Casale A, Tatarelli R, Baldessarini RJ. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. Hum Psychopharmacol. 2009 Apr; 24(3):177-90. PMID: 19229839.
    View in: PubMed
  174. Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord. 2009 Dec; 119(1-3):22-7. PMID: 19324419.
    View in: PubMed
  175. Baldessarini RJ, Tondo L. Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants. Pharmacopsychiatry. 2009 Mar; 42(2):72-5. PMID: 19308882.
    View in: PubMed
  176. Wingo AP, Harvey PD, Baldessarini RJ. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord. 2009 Mar; 11(2):113-25. PMID: 19267694.
    View in: PubMed
  177. Trede K, Baldessarini RJ, Viguera AC, Bottero A. Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary. Harv Rev Psychiatry. 2009; 17(2):157-65. PMID: 19373623.
    View in: PubMed
  178. Vigo DV, Baldessarini RJ. Anticonvulsants in the treatment of major depressive disorder: an overview. Harv Rev Psychiatry. 2009; 17(4):231-41. PMID: 19637072.
    View in: PubMed
  179. Gross A, Altman M, Salvatore P, Baldessarini RJ, Chanoff M, Powers JP. An atypical, chronic psychotic disorder in a 55-year-old man. Harv Rev Psychiatry. 2009; 17(5):329-43. PMID: 19832047.
    View in: PubMed
  180. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA, Vieta E, Maggini C. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2009 Apr; 70(4):458-66. PMID: 19200422.
    View in: PubMed
  181. Baldessarini RJ. Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression". J Clin Psychopharmacol. 2008 Dec; 28(6):716; author reply 717-8. PMID: 19011451.
    View in: PubMed
  182. Si YG, Choi YK, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines. Bioorg Med Chem Lett. 2009 Jan 01; 19(1):51-3. PMID: 19058967.
    View in: PubMed
  183. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv. 2008 Oct; 59(10):1175-83. PMID: 18832504.
    View in: PubMed
  184. Baethge C, Hennen J, Khalsa HM, Salvatore P, Tohen M, Baldessarini RJ. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord. 2008 Sep; 10(6):738-41. PMID: 18837869.
    View in: PubMed
  185. Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand. 2008 Nov; 118(5):347-56. PMID: 18727689; PMCID: PMC2718794.
  186. Sim K, Chuan Su H, Fujii S, Yang SY, Chong MY, Si T, Ling He Y, Kee Chung E, Huak Chan Y, Shinfuku N, Hoon Tan C, Ungvari G, Baldessarini RJ. Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001. Int J Neuropsychopharmacol. 2009 Feb; 12(1):117-23. PMID: 18706129.
    View in: PubMed
  187. Talamo A, Baldessarini RJ, Centorrino F. Comparison of mania patients suitable for treatment trials versus clinical treatment. Hum Psychopharmacol. 2008 Aug; 23(6):447-54. PMID: 18484680; PMCID: PMC2643874.
  188. Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ. Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry. 2008 Jul; 193(1):10-7. PMID: 18700212.
    View in: PubMed
  189. Si YG, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines. Bioorg Med Chem Lett. 2008 Jul 15; 18(14):3971-3. PMID: 18585036.
    View in: PubMed
  190. Newport DJ, Stowe ZN, Viguera AC, Calamaras MR, Juric S, Knight B, Pennell PB, Baldessarini RJ. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord. 2008 May; 10(3):432-6. PMID: 18402631.
    View in: PubMed
  191. Tondo L, Lepri B, Baldessarini RJ. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Acta Psychiatr Scand. 2008 Aug; 118(2):106-15. PMID: 18397362.
    View in: PubMed
  192. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008 Mar; 23(2):95-105. PMID: 18058849.
    View in: PubMed
  193. Salvatore P, Ghidini S, Zita G, De Panfilis C, Lambertino S, Maggini C, Baldessarini RJ. Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord. 2008 Mar; 10(2):256-65. PMID: 18271904.
    View in: PubMed
  194. Si YG, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity. J Med Chem. 2008 Feb 28; 51(4):983-7. PMID: 18251489.
    View in: PubMed
  195. Baldessarini RJ, Tondo L. Lithium and suicidal risk. Bipolar Disord. 2008 Feb; 10(1):114-5. PMID: 18199250.
    View in: PubMed
  196. Nykiel SA, Baldessarini RJ, Bower MC, Goodwin J, Salvatore P. Psychosis NOS: search for diagnostic clarity. Harv Rev Psychiatry. 2008; 16(1):55-65. PMID: 18306099.
    View in: PubMed
  197. Salvatore P, Bhuvaneswar C, Ebert D, Maggini C, Baldessarini RJ. Cycloid psychoses revisited: case reports, literature review, and commentary. Harv Rev Psychiatry. 2008; 16(3):167-80. PMID: 18569038.
    View in: PubMed
  198. Bois F, Baldwin RM, Amici L, Al-Tikriti MS, Kula N, Baldessarini R, Innis RB, Staley JK, Tamagnan GD. Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer. Nucl Med Biol. 2008 Jan; 35(1):53-9. PMID: 18158943; PMCID: PMC2276982.
  199. Frankenburg FR, Baldessarini RJ. Neurosyphilis, malaria, and the discovery of antipsychotic agents. Harv Rev Psychiatry. 2008; 16(5):299-307. PMID: 18803105.
    View in: PubMed
  200. Tondo L, Lepri B, Baldessarini RJ. Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand. 2007 Dec; 116(6):419-28. PMID: 17997721.
    View in: PubMed
  201. Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, Zurick A, Cohen LS. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007 Dec; 164(12):1817-24; quiz 1923. PMID: 18056236.
    View in: PubMed
  202. Centorrino F, Cincotta SL, Talamo A, Fogarty KV, Guzzetta F, Saadeh MG, Salvatore P, Baldessarini RJ. Hospital use of antipsychotic drugs: polytherapy. Compr Psychiatry. 2008 Jan-Feb; 49(1):65-9. PMID: 18063043.
    View in: PubMed
  203. Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007 Aug; 164(8):1198-205. PMID: 17671282.
    View in: PubMed
  204. Kyomen HH, Whitfield TH, Baldessarini RJ. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type. J Clin Psychopharmacol. 2007 Aug; 27(4):408-10. PMID: 17632234.
    View in: PubMed
  205. Khalsa HM, Salvatore P, Hennen J, Baethge C, Tohen M, Baldessarini RJ. Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord. 2008 Feb; 106(1-2):179-84. PMID: 17614135.
    View in: PubMed
  206. Baldessarini RJ, Tondo L, Strombom IM, Dominguez S, Fawcett J, Licinio J, Oquendo MA, Tollefson GD, Valuck RJ, Tohen M. Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry. 2007 Jul-Aug; 15(4):133-45. PMID: 17687708.
    View in: PubMed
  207. Baldessarini RJ, Tondo L, Baethge CJ, Lepri B, Bratti IM. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disord. 2007 Jun; 9(4):386-93. PMID: 17547585.
    View in: PubMed
  208. Si YG, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands. Bioorg Med Chem Lett. 2007 Aug 01; 17(15):4128-30. PMID: 17543523.
    View in: PubMed
  209. Salvatore P, Tohen M, Khalsa HM, Baethge C, Tondo L, Baldessarini RJ. Longitudinal research on bipolar disorders. Epidemiol Psichiatr Soc. 2007 Apr-Jun; 16(2):109-17. PMID: 17619540.
    View in: PubMed
  210. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry. 2007 Mar; 68(3):380-3. PMID: 17388706.
    View in: PubMed
  211. Viguera AC, Newport DJ, Ritchie J, Stowe Z, Whitfield T, Mogielnicki J, Baldessarini RJ, Zurick A, Cohen LS. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007 Feb; 164(2):342-5. PMID: 17267800.
    View in: PubMed
  212. Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 2007 Feb-Mar; 9(1-2):183-96. PMID: 17391360.
    View in: PubMed
  213. Zhang A, Zhang Y, Branfman AR, Baldessarini RJ, Neumeyer JL. Advances in development of dopaminergic aporphinoids. J Med Chem. 2007 Jan 25; 50(2):171-81. PMID: 17228858.
    View in: PubMed
  214. Zhang A, Neumeyer JL, Baldessarini RJ. Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev. 2007 Jan; 107(1):274-302. PMID: 17212477.
    View in: PubMed
  215. Ghaemi SN, Baldessarini RJ. The manic-depressive spectrum and mood stabilization: Kraepelin's ghost. Psychother Psychosom. 2007; 76(2):65-9. PMID: 17230046.
    View in: PubMed
  216. Viguera AC, Koukopoulos A, Muzina DJ, Baldessarini RJ. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry. 2007; 68 Suppl 9:29-33. PMID: 17764382.
    View in: PubMed
  217. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv. 2007 Jan; 58(1):85-91. PMID: 17215417.
    View in: PubMed
  218. Moran-Gates T, Grady C, Shik Park Y, Baldessarini RJ, Tarazi FI. Effects of risperidone on dopamine receptor subtypes in developing rat brain. Eur Neuropsychopharmacol. 2007 May-Jun; 17(6-7):448-55. PMID: 17175142; PMCID: PMC1931412.
  219. Acharya N, Rosen AS, Polzer JP, D'Souza DN, Perahia DG, Cavazzoni PA, Baldessarini RJ. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol. 2006 Dec; 26(6):587-94. PMID: 17110815.
    View in: PubMed
  220. Sim K, Lee NB, Chua HC, Mahendran R, Fujii S, Yang SY, Chong MY, Si T, He YL, Lee MS, Sung KM, Chung EK, Chan YH, Shinfuku N, Tan CH, Sartorius N, Baldessarini RJ. Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol. 2007 Apr; 63(4):431-7. PMID: 17076698; PMCID: PMC2203241.
  221. Tamagnan GD, Brenner E, Alagille D, Staley JK, Haile C, Koren A, Early M, Baldwin RM, Tarazi FI, Baldessarini RJ, Jarkas N, Goodman MM, Seibyl JP. Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorg Med Chem Lett. 2007 Jan 15; 17(2):533-7. PMID: 17095215; PMCID: PMC1806685.
  222. Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Al Tikriti M, Innis RB, Tamagnan GD. Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(4'-p-substituted phenyl)-piperidine analogs of cocaine. Bioorg Med Chem Lett. 2006 Oct 01; 16(19):5222-5. PMID: 16908151.
    View in: PubMed
  223. Gonzalez-Pinto A, Mosquera F, Alonso M, López P, Ramírez F, Vieta E, Baldessarini RJ. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 2006 Oct; 8(5 Pt 2):618-24. PMID: 17042834.
    View in: PubMed
  224. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006 Oct; 8(5 Pt 2):625-39. PMID: 17042835.
    View in: PubMed
  225. Pantazopoulos H, Lange N, Baldessarini RJ, Berretta S. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry. 2007 Mar 01; 61(5):640-52. PMID: 16950219; PMCID: PMC1964505.
  226. Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. J Clin Psychiatry. 2006 Aug; 67(8):1246-52. PMID: 16965203.
    View in: PubMed
  227. Salvatore P, Khalsa HM, Hennen J, Tohen M, Yurgelun-Todd D, Casolari F, Depanfilis C, Maggini C, Baldessarini RJ. Psychopathology factors in first-episode affective and non-affective psychotic disorders. J Psychiatr Res. 2007 Nov; 41(9):724-36. PMID: 16762370.
    View in: PubMed
  228. Talamo A, Centorrino F, Tondo L, Dimitri A, Hennen J, Baldessarini RJ. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res. 2006 Sep; 86(1-3):251-5. PMID: 16750347.
    View in: PubMed
  229. Baldessarini RJ, Pompili M, Tondo L. Suicide in bipolar disorder: Risks and management. CNS Spectr. 2006 Jun; 11(6):465-71. PMID: 16816785.
    View in: PubMed
  230. Centorrino F, Wurtman JJ, Duca KA, Fellman VH, Fogarty KV, Berry JM, Guay DM, Romeling M, Kidwell J, Cincotta SL, Baldessarini RJ. Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes (Lond). 2006 Jun; 30(6):1011-6. PMID: 16432547.
    View in: PubMed
  231. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord. 2006 May; 21(5):589-98. PMID: 16532448.
    View in: PubMed
  232. Tondo L, Baldessarini RJ. Strategies to prevent suicide. JAMA. 2006 Apr 05; 295(13):1515; author reply 1516. PMID: 16595754.
    View in: PubMed
  233. Tondo L, Albert MJ, Baldessarini RJ. Suicide rates in relation to health care access in the United States: an ecological study. J Clin Psychiatry. 2006 Apr; 67(4):517-23. PMID: 16669716.
    View in: PubMed
  234. Centorrino F, Hennen J, Mallya G, Egli S, Clark T, Baldessarini RJ. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both. Hum Psychopharmacol. 2006 Apr; 21(3):189-93. PMID: 16625524.
    View in: PubMed
  235. Baldessarini RJ, Pompili M, Tondo L. Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry. 2006 Mar; 63(3):246-8. PMID: 16520428.
    View in: PubMed
  236. Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D, Wagner KD. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology. 2006 Mar; 31(3):473-92. PMID: 16319919.
    View in: PubMed
  237. Moran-Gates T, Gan L, Park YS, Zhang K, Baldessarini RJ, Tarazi FI. Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse. 2006 Feb; 59(2):92-100. PMID: 16270300.
    View in: PubMed
  238. Tóth M, Berényi S, Csutorás C, Kula NS, Zhang K, Baldessarini RJ, Neumeyer JL. Synthesis and dopamine receptor binding of sulfur-containing aporphines. Bioorg Med Chem. 2006 Mar 15; 14(6):1918-23. PMID: 16290940.
    View in: PubMed
  239. Tamagnan G, Alagille D, Fu X, Kula NS, Baldessarini RJ, Innis RB, Baldwin RM. Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[aryl or heteroaryl]phenyltropanes. Bioorg Med Chem Lett. 2006 Jan 01; 16(1):217-20. PMID: 16236497.
    View in: PubMed
  240. Grant MJ, Baldessarini RJ. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Ann Pharmacother. 2005 Nov; 39(11):1953. PMID: 16219895.
    View in: PubMed
  241. Centorrino F, Fogarty KV, Sani G, Salvatore P, Cincotta SL, Hennen J, Guzzetta F, Talamo A, Saadeh MG, Baldessarini RJ. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol. 2005 Oct; 20(7):485-92. PMID: 16116665.
    View in: PubMed
  242. Minnai GP, Tondo L, Salis P, Ghiani C, Manfredi A, Paluello MM, Baethge C, Baldessarini RJ. Secular trends in first hospitalizations for major mood disorders with comorbid substance use. Int J Neuropsychopharmacol. 2006 Jun; 9(3):319-26. PMID: 16316480.
    View in: PubMed
  243. Derenne JL, Baldessarini RJ. Clozapine toxicity associated with smoking cessation: case report. Am J Ther. 2005 Sep-Oct; 12(5):469-71. PMID: 16148433.
    View in: PubMed
  244. Centorrino F, Fogarty KV, Sani G, Salvatore P, Cimbolli P, Baldessarini RJ. Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol. 2005 Jul; 20(5):355-8. PMID: 15957153.
    View in: PubMed
  245. Soldani F, Ghaemi SN, Baldessarini RJ. Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality. Acta Psychiatr Scand. 2005 Jul; 112(1):72-4. PMID: 15952948.
    View in: PubMed
  246. Centorrino F, Fogarty KV, Cimbolli P, Salvatore P, Thompson TA, Sani G, Cincotta SL, Baldessarini RJ. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. J Psychiatr Pract. 2005 Jul; 11(4):241-7. PMID: 16041234.
    View in: PubMed
  247. Soldani F, Ghaemi SN, Baldessarini R. Research methods in psychiatric treatment studies. Critique and proposals. Acta Psychiatr Scand. 2005 Jul; 112(1):1-3. PMID: 15952939.
    View in: PubMed
  248. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. CMAJ. 2005 Jun 21; 172(13):1703-11. PMID: 15967975; PMCID: PMC1150265.
  249. Trede K, Salvatore P, Baethge C, Gerhard A, Maggini C, Baldessarini RJ. Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry. 2005 May-Jun; 13(3):155-78. PMID: 16020028.
    View in: PubMed
  250. Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry. 2005 May; 162(5):1008-10. PMID: 15863809.
    View in: PubMed
  251. Moran-Gates T, Zhang K, Baldessarini RJ, Tarazi FI. Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2005 Sep; 8(3):439-44. PMID: 15817135.
    View in: PubMed
  252. Baethge C, Baldessarini RJ, Freudenthal K, Streeruwitz A, Bauer M, Bschor T. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord. 2005 Apr; 7(2):136-45. PMID: 15762854.
    View in: PubMed
  253. Lasser RA, Bossie CA, Gharabawi GM, Baldessarini RJ. Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial. Int J Neuropsychopharmacol. 2005 Sep; 8(3):427-38. PMID: 15804371.
    View in: PubMed
  254. Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res. 2005 Mar 01; 73(2-3):139-45. PMID: 15653256.
    View in: PubMed
  255. Baldessarini RJ, Faedda GL, Hennen J. Risk of mania with antidepressants. Arch Pediatr Adolesc Med. 2005 Mar; 159(3):298; author reply 298-9. PMID: 15753278.
    View in: PubMed
  256. Zhu MY, Wang WP, Baldessarini RJ, Kim KS. Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue. Brain Res Mol Brain Res. 2005 Feb 18; 133(2):167-75. PMID: 15710233.
    View in: PubMed
  257. Tamagnan G, Alagille D, Fu X, Kula NS, Baldessarini RJ, Innis RB, Baldwin RM. Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency. Bioorg Med Chem Lett. 2005 Feb 15; 15(4):1131-3. PMID: 15686927.
    View in: PubMed
  258. Chengappa KN, Hennen J, Baldessarini RJ, Kupfer DJ, Yatham LN, Gershon S, Baker RW, Tohen M. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord. 2005 Feb; 7(1):68-76. PMID: 15654934.
    View in: PubMed
  259. Baethge C, Baldessarini RJ, Mathiske-Schmidt K, Hennen J, Berghöfer A, Müller-Oerlinghausen B, Bschor T, Adli M, Bauer M. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005 Feb; 66(2):174-82. PMID: 15705002.
    View in: PubMed
  260. Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ. Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry. 2004 Dec; 65(12):1679-87. PMID: 15641874.
    View in: PubMed
  261. Peng X, Zhang A, Kula NS, Baldessarini RJ, Neumeyer JL. Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents. Bioorg Med Chem Lett. 2004 Nov 15; 14(22):5635-9. PMID: 15482938.
    View in: PubMed
  262. Centorrino F, MacLean E, Salvatore P, Kidwell JE, Fogarty KV, Berry JM, Baldessarini RJ. Ziprasidone: first year experience in a hospital setting. J Psychiatr Pract. 2004 Nov; 10(6):361-7. PMID: 15583517.
    View in: PubMed
  263. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord. 2004 Oct 01; 82(1):149-58. PMID: 15465590.
    View in: PubMed
  264. Vieta E, Calabrese JR, Hennen J, Colom F, Martínez-Arán A, Sánchez-Moreno J, Yatham LN, Tohen M, Baldessarini RJ. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry. 2004 Oct; 65(10):1420-8. PMID: 15491248.
    View in: PubMed
  265. Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ. Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology. 2004 Sep; 29(9):1648-55. PMID: 15138447.
    View in: PubMed
  266. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord. 2004 Aug; 6(4):305-13. PMID: 15225148.
    View in: PubMed
  267. Tarazi FI, Zhang K, Baldessarini RJ. Dopamine D4 receptors: beyond schizophrenia. J Recept Signal Transduct Res. 2004 Aug; 24(3):131-47. PMID: 15521359.
    View in: PubMed
  268. Csutoras C, Zhang A, Zhang K, Kula NS, Baldessarini RJ, Neumeyer JL. Synthesis and neuropharmacological evaluation of R(-)-N-alkyl-11-hydroxynoraporphines and their esters. Bioorg Med Chem. 2004 Jul 01; 12(13):3553-9. PMID: 15186839.
    View in: PubMed
  269. Baethge C, Glovinsky I, Baldessarini RJ. Manic-depressive illness in children: an early twentieth-century view by Theodor Ziehen (1862-1950). Introduction. Hist Psychiatry. 2004 Jun; 15(58 Pt 2):201-26. PMID: 15272482.
    View in: PubMed
  270. Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G. Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT). Bioorg Med Chem Lett. 2004 May 03; 14(9):2117-20. PMID: 15080991.
    View in: PubMed
  271. Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004 Apr; 161(4):700-6. PMID: 15056517.
    View in: PubMed
  272. Oepen G, Baldessarini RJ, Salvatore P, Slater E. On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary. J Affect Disord. 2004 Jan; 78(1):1-9. PMID: 14672791.
    View in: PubMed
  273. Gan L, Falzone TL, Zhang K, Rubinstein M, Baldessarini RJ, Tarazi FI. Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci. 2004; 22(3):167-78. PMID: 14997010.
    View in: PubMed
  274. Baldessarini RJ, Hennen J. Genetics of suicide: an overview. Harv Rev Psychiatry. 2004 Jan-Feb; 12(1):1-13. PMID: 14965851.
    View in: PubMed
  275. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004 Jan; 161(1):163-5. PMID: 14702267.
    View in: PubMed
  276. Tohen M, Zarate CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003 Dec; 160(12):2099-107. PMID: 14638578.
    View in: PubMed
  277. Baldwin RM, Fu X, Kula NS, Baldessarini RJ, Amici L, Innis RB, Tamagnan GD. Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM. Bioorg Med Chem Lett. 2003 Nov 17; 13(22):4015-7. PMID: 14592497.
    View in: PubMed
  278. Centorrino F, Albert MJ, Berry JM, Kelleher JP, Fellman V, Line G, Koukopoulos AE, Kidwell JE, Fogarty KV, Baldessarini RJ. Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bipolar Disord. 2003 Oct; 5(5):370-4. PMID: 14525559.
    View in: PubMed
  279. Baldessarini RJ, Tondo L. Suicide risk and treatments for patients with bipolar disorder. JAMA. 2003 Sep 17; 290(11):1517-9. PMID: 13129995.
    View in: PubMed
  280. Baethge C, Salvatore P, Baldessarini RJ. Cyclothymia, a circular mood disorder. Hist Psychiatry. 2003 09; 14(55 Pt 3):377-99. PMID: 14621693.
    View in: PubMed
  281. Bratti IM, Baldessarini RJ, Baethge C, Tondo L. Pretreatment episode count and response to lithium treatment in manic-depressive illness. Harv Rev Psychiatry. 2003 Sep-Oct; 11(5):245-56. PMID: 14555425.
    View in: PubMed
  282. Meltzer HY, Baldessarini RJ. Reducing the risk for suicide in schizophrenia and affective disorders. J Clin Psychiatry. 2003 Sep; 64(9):1122-9. PMID: 14628990.
    View in: PubMed
  283. Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol. 2003 Aug 08; 474(2-3):137-40. PMID: 12921854.
    View in: PubMed
  284. Baethge C, Tondo L, Bratti IM, Bschor T, Bauer M, Viguera AC, Baldessarini RJ. Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry. 2003 Aug; 48(7):449-57. PMID: 12971014.
    View in: PubMed
  285. Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE, McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate CA, Baker RW, Tohen M. Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol. 2003 Aug; 23(4):370-6. PMID: 12920413.
    View in: PubMed
  286. Centorrino F, Kelleher JP, Berry JM, Salvatore P, Eakin M, Fogarty KV, Fellman V, Baldessarini RJ. Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry. 2003 Jul; 160(7):1348-50. PMID: 12832255.
    View in: PubMed
  287. Centorrino F, Albert MJ, Drago-Ferrante G, Koukopoulos AE, Berry JM, Baldessarini RJ. Delirium during clozapine treatment: incidence and associated risk factors. Pharmacopsychiatry. 2003 Jul; 36(4):156-60. PMID: 12905102.
    View in: PubMed
  288. Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand. 2003 Jul; 108(1):4-14. PMID: 12807371.
    View in: PubMed
  289. Glod CA, Lynch A, Flynn E, Berkowitz C, Baldessarini RJ. Open trial of bupropion SR in adolescent major depression. J Child Adolesc Psychiatr Nurs. 2003 Jul-Sep; 16(3):123-30. PMID: 14603988.
    View in: PubMed
  290. Tarazi FI, Baldessarini RJ, Kula NS, Zhang K. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment. J Pharmacol Exp Ther. 2003 Sep; 306(3):1145-51. PMID: 12829726.
    View in: PubMed
  291. Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 2003 Jun; 5(3):169-79. PMID: 12780871.
    View in: PubMed
  292. Beresin EV, Baldessarini RJ, Alpert J, Rosenbaum J. Teaching ethics of psychopharmacology research in psychiatric residency training programs. Psychopharmacology (Berl). 2003 Dec; 171(1):105-11. PMID: 12677357.
    View in: PubMed
  293. Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev. 2003 Apr; 42(1):1-21. PMID: 12668288.
    View in: PubMed
  294. Baldessarini RJ. Assessment of treatment response in mania: commentary and new findings. Bipolar Disord. 2003 Apr; 5(2):79-84. PMID: 12680896.
    View in: PubMed
  295. Baethge C, Salvatore P, Baldessarini RJ. "On cyclic insanity" by Karl Ludwig Kahlbaum, MD: a translation and commentary. Harv Rev Psychiatry. 2003 Mar-Apr; 11(2):78-90. PMID: 12868508.
    View in: PubMed
  296. Joffe H, Hall JE, Cohen LS, Taylor AE, Baldessarini RJ. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Harv Rev Psychiatry. 2003 Mar-Apr; 11(2):99-108. PMID: 12868510.
    View in: PubMed
  297. Frazier JA, Cohen LG, Jacobsen L, Grothe D, Flood J, Baldessarini RJ, Piscitelli S, Kim GS, Rapoport JL. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia. J Clin Psychopharmacol. 2003 Feb; 23(1):87-91. PMID: 12544379.
    View in: PubMed
  298. Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003; 17(7):491-511. PMID: 12751919.
    View in: PubMed
  299. Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry. 2003; 64 Suppl 5:44-52. PMID: 12720484.
    View in: PubMed
  300. Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain. Nitric Oxide. 2002 Dec; 7(4):297-300. PMID: 12446179.
    View in: PubMed
  301. Viguera AC, Cohen LS, Bouffard S, Whitfield TH, Baldessarini RJ. Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry. 2002 Dec; 159(12):2102-4. PMID: 12450965.
    View in: PubMed
  302. Centorrino F, Eakin M, Bahk WM, Kelleher JP, Goren J, Salvatore P, Egli S, Baldessarini RJ. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry. 2002 Nov; 159(11):1932-5. PMID: 12411232.
    View in: PubMed
  303. Viguera AC, Cohen LJ, Tondo L, Baldessarini RJ. Protective effect of pregnancy on the course of lithium-responsive bipolar I disorder. J Affect Disord. 2002 Oct; 72(1):107-8; author reply 103-5. PMID: 12204325.
    View in: PubMed
  304. Salvatore P, Baldessarini RJ, Centorrino F, Egli S, Albert M, Gerhard A, Maggini C. Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry. 2002 Sep-Oct; 10(5):255-75. PMID: 12202452.
    View in: PubMed
  305. Zhang K, Davids E, Tarazi FI, Baldessarini RJ. Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res. 2002 Aug 30; 137(2):135-8. PMID: 12220705.
    View in: PubMed
  306. Zhu MY, Kim CH, Hwang DY, Baldessarini RJ, Kim KS. Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue. J Neurochem. 2002 Jul; 82(1):146-53. PMID: 12091475.
    View in: PubMed
  307. Baldessarini RJ, Ghaemi SN, Viguera AC. Tolerance in antidepressant treatment. Psychother Psychosom. 2002 Jul-Aug; 71(4):177-9. PMID: 12097781.
    View in: PubMed
  308. Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther. 2002 Jun; 301(3):1097-102. PMID: 12023542.
    View in: PubMed
  309. Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry. 2002 Jun; 47(5):426-36. PMID: 12085677.
    View in: PubMed
  310. Fu X, Tan PZ, Kula NS, Baldessarini R, Tamagnan G, Innis RB, Baldwin RM. Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging. J Med Chem. 2002 May 23; 45(11):2319-24. PMID: 12014970.
    View in: PubMed
  311. Zhang K, Tarazi FI, Davids E, Baldessarini RJ. Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology. 2002 May; 26(5):625-33. PMID: 11927187.
    View in: PubMed
  312. Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl). 2002 May; 161(3):263-70. PMID: 12021829.
    View in: PubMed
  313. Zhang K, Davids E, Tarazi FI, Baldessarini RJ. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl). 2002 Apr; 161(1):100-6. PMID: 11967637.
    View in: PubMed
  314. Baldessarini RJ, Tondo L, Hennen J, Viguera AC. Is lithium still worth using? An update of selected recent research. Harv Rev Psychiatry. 2002 Mar-Apr; 10(2):59-75. PMID: 11897747.
    View in: PubMed
  315. Kelleher JP, Centorrino F, Albert MJ, Baldessarini RJ. Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. CNS Drugs. 2002; 16(4):249-61. PMID: 11945108.
    View in: PubMed
  316. Cesati RR, Tamagnan G, Baldwin RM, Zoghbi SS, Innis RB, Kula NS, Baldessarini RJ, Katzenellenbogen JA. Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter. Bioconjug Chem. 2002 Jan-Feb; 13(1):29-39. PMID: 11792176.
    View in: PubMed
  317. Baldessarini RJ. Treatment research in bipolar disorder: issues and recommendations. CNS Drugs. 2002; 16(11):721-9. PMID: 12383028.
    View in: PubMed
  318. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs. 2002; 16(1):23-45. PMID: 11772117.
    View in: PubMed
  319. Centorrino F, Price BH, Tuttle M, Bahk WM, Hennen J, Albert MJ, Baldessarini RJ. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002 Jan; 159(1):109-15. PMID: 11772698.
    View in: PubMed
  320. Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl). 2002 Feb; 160(1):92-8. PMID: 11862378.
    View in: PubMed
  321. Gu XH, Zong R, Kula NS, Baldessarini RJ, Neumeyer JL. Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter. Bioorg Med Chem Lett. 2001 Dec 03; 11(23):3049-53. PMID: 11714608.
    View in: PubMed
  322. Zhang K, Tarazi FI, Baldessarini RJ. Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology. 2001 Nov; 25(5):624-32. PMID: 11682245.
    View in: PubMed
  323. Viguera AC, Baldessarini RJ, Tondo L. Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disord. 2001 Oct; 3(5):245-52. PMID: 11903207.
    View in: PubMed
  324. Baldessarini RJ, Tondo L. Long-term lithium for bipolar disorder. Am J Psychiatry. 2001 Oct; 158(10):1740. PMID: 11579023.
    View in: PubMed
  325. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand. 2001 Sep; 104(3):163-72. PMID: 11531653.
    View in: PubMed
  326. Faedda GL, Tondo L, Baldessarini RJ. Lithium discontinuation: uncovering latent bipolar disorder? Am J Psychiatry. 2001 Aug; 158(8):1337-9. PMID: 11481189.
    View in: PubMed
  327. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry. 2001 Jul; 62(7):565-9. PMID: 11488370.
    View in: PubMed
  328. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry Suppl. 2001 Jun; 41:s184-90. PMID: 11450181.
    View in: PubMed
  329. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry. 2001 Jun; 178(Suppl 41):S184-90. PMID: 11388960.
    View in: PubMed
  330. Zhang K, Tarazi FI, Baldessarini RJ. Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen. Pharmacol Biochem Behav. 2001 May-Jun; 69(1-2):111-6. PMID: 11420075.
    View in: PubMed
  331. Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther. 2001 May; 297(2):711-7. PMID: 11303062.
    View in: PubMed
  332. Baldessarini RJ, Tondo L, Hennen J. Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. Ann N Y Acad Sci. 2001 Apr; 932:24-38; discussion 39-43. PMID: 11411189.
    View in: PubMed
  333. Centorrino F, Hernán MA, Drago-Ferrante G, Rendall M, Apicella A, Längar G, Baldessarini RJ. Factors associated with noncompliance with psychiatric outpatient visits. Psychiatr Serv. 2001 Mar; 52(3):378-80. PMID: 11239109.
    View in: PubMed
  334. Baldessarini RJ, Campbell A, Webb NL, Swindell CS, Flood JG, Shashoua VE, Kula NS, Hemamalini S, Bradley MO. Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat. Neuropsychopharmacology. 2001 Jan; 24(1):55-65. PMID: 11106876.
    View in: PubMed
  335. Baldessarini RJ, Tondo L, Floris G, Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord. 2000 Dec; 61(1-2):13-22. PMID: 11099736.
    View in: PubMed
  336. Tarazi FI, Zhang K, Baldessarini RJ. Effects of nigrostriatal dopamine denervation on ionotropic glutamate receptors in rat caudate-putamen. Brain Res. 2000 Oct 20; 881(1):69-72. PMID: 11033095.
    View in: PubMed
  337. Tohen M, Strakowski SM, Zarate C, Hennen J, Stoll AL, Suppes T, Faedda GL, Cohen BM, Gebre-Medhin P, Baldessarini RJ. The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry. 2000 Sep 15; 48(6):467-76. PMID: 11018220.
    View in: PubMed
  338. Huxley NA, Parikh SV, Baldessarini RJ. Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv Rev Psychiatry. 2000 Sep; 8(3):126-40. PMID: 10973937.
    View in: PubMed
  339. Viguera AC, Tondo L, Baldessarini RJ. Sex differences in response to lithium treatment. Am J Psychiatry. 2000 Sep; 157(9):1509-11. PMID: 10964872.
    View in: PubMed
  340. Tarazi FI, Kula NS, Zhang K, Baldessarini RJ. Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ. Neuropharmacology. 2000 Aug 23; 39(11):2133-8. PMID: 10963756.
    View in: PubMed
  341. Tamagnan G, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB. Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(2''-, 3''- or 4''-substituted) biphenyltropanes. Bioorg Med Chem Lett. 2000 Aug 21; 10(16):1783-5. PMID: 10969967.
    View in: PubMed
  342. Tarazi FI, Zhang K, Baldessarini RJ. Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain. Neurosci Lett. 2000 Jun 23; 287(2):81-4. PMID: 10854717.
    View in: PubMed
  343. Tamagnan G, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB. Cyclopentadienyltricarbonylrheniumbenzazepines: synthesis and binding affinity. Bioorg Med Chem Lett. 2000 May 15; 10(10):1113-5. PMID: 10843230.
    View in: PubMed
  344. Baldessarini RJ, Tohen M, Tondo L. Maintenance treatment in bipolar disorder. Arch Gen Psychiatry. 2000 May; 57(5):490-2. PMID: 10807489.
    View in: PubMed
  345. Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Disord. 2000 Mar; 2(1):3-7. PMID: 11254017.
    View in: PubMed
  346. Tarazi FI, Baldessarini RJ. Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int J Dev Neurosci. 2000 Feb; 18(1):29-37. PMID: 10708903.
    View in: PubMed
  347. Tohen M, Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000 Feb; 157(2):220-8. PMID: 10671390.
    View in: PubMed
  348. Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry. 2000 Feb; 57(2):187-90. PMID: 10665622.
    View in: PubMed
  349. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000 Feb; 157(2):179-84. PMID: 10671384.
    View in: PubMed
  350. Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J Clin Psychiatry. 2000; 61 Suppl 9:97-104. PMID: 10826667.
    View in: PubMed
  351. Zhang K, Tarazi FI, Campbell A, Baldessarini RJ. GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine. Neuroscience. 2000; 101(1):5-10. PMID: 11068131.
    View in: PubMed
  352. Zhang K, Tarazi FI, Baldessarini RJ. Dopamine D(4) receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization. Neuroscience. 2000; 97(2):211-3. PMID: 10799752.
    View in: PubMed
  353. Kula NS, Baldessarini RJ, Tarazi FI, Fisser R, Wang S, Trometer J, Neumeyer JL. [3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue. Eur J Pharmacol. 1999 Dec 03; 385(2-3):291-4. PMID: 10607889.
    View in: PubMed
  354. Baldessarini RJ, Tondo L, Hennen J, Floris G. Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. Bipolar Disord. 1999 Dec; 1(2):91-7. PMID: 11252665.
    View in: PubMed
  355. Zhang K, Weiss NT, Tarazi FI, Kula NS, Baldessarini RJ. Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine. Brain Res. 1999 Nov 13; 847(1):32-7. PMID: 10564733.
    View in: PubMed
  356. Tarazi FI, Baldessarini RJ. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry. 1999 Nov; 4(6):529-38. PMID: 10578234.
    View in: PubMed
  357. Zhang K, Tarazi FI, Kula NS, Baldessarini RJ, Neumeyer JL. Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone. Neurosci Lett. 1999 Oct 29; 274(3):155-8. PMID: 10548413.
    View in: PubMed
  358. Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord. 1999 Sep; 1(1):17-24. PMID: 11256650.
    View in: PubMed
  359. Baldessarini RJ, Viguera AC. Relapse of depressive symptoms after discontinuing sertraline. JAMA. 1999 Jul 28; 282(4):323-4. PMID: 10432022.
    View in: PubMed
  360. Baldessarini RJ, Tondo L, Hennen J. Treatment delays in bipolar disorders. Am J Psychiatry. 1999 May; 156(5):811-2. PMID: 10327940.
    View in: PubMed
  361. Tarazi FI, Baldessarini RJ. Brain dopamine D(4) receptors: basic and clinical status. Int J Neuropsychopharmacol. 1999 Mar; 2(1):41-58. PMID: 11281970.
    View in: PubMed
  362. Tarazi FI, Baldessarini RJ. Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions. J Neurosci Res. 1999 Feb 15; 55(4):401-10. PMID: 10723051.
    View in: PubMed
  363. Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands. Eur J Pharmacol. 1999 Feb 12; 367(1):139-42. PMID: 10082277.
    View in: PubMed
  364. Tamagnan G, Gao Y, Xu L, Kula NS, Baldessarini RJ, Neumeyer JL. Nonisotopic surrogates for technetium as ligands for monoamine transporters. Adv Neurol. 1999; 80:99-103. PMID: 10410707.
    View in: PubMed
  365. Tondo L, Baldessarini RJ, Hennen J, Minnai GP, Salis P, Scamonatti L, Masia M, Ghiani C, Mannu P. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry. 1999; 60 Suppl 2:63-9; discussion 75-6, 113-6. PMID: 10073390.
    View in: PubMed
  366. Baldessarini RJ, Jamison KR. Effects of medical interventions on suicidal behavior. Summary and conclusions. J Clin Psychiatry. 1999; 60 Suppl 2:117-22. PMID: 10073398.
    View in: PubMed
  367. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev Neurosci. 1999; 21(1):43-9. PMID: 10077701.
    View in: PubMed
  368. Jamison KR, Baldessarini RJ. Effects of medical interventions on suicidal behavior. Introduction. J Clin Psychiatry. 1999; 60 Suppl 2:4-6; discussion 113-6. PMID: 10073381.
    View in: PubMed
  369. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry. 1999; 60 Suppl 2:77-84; discussion 111-6. PMID: 10073392.
    View in: PubMed
  370. Baldessarini RJ, Viguera AC, Tondo L. Discontinuing psychotropic agents. J Psychopharmacol. 1999; 13(3):292-3; discussion 299. PMID: 10512088.
    View in: PubMed
  371. Siegel AJ, Baldessarini RJ, Klepser MB, McDonald JC. Primary and drug-induced disorders of water homeostasis in psychiatric patients: principles of diagnosis and management. Harv Rev Psychiatry. 1998 Nov-Dec; 6(4):190-200. PMID: 10370444.
    View in: PubMed
  372. Tarazi FI, Campbell A, Baldessarini RJ. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors. Neuroscience. 1998 Nov; 87(1):1-4. PMID: 9722137.
    View in: PubMed
  373. Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry. 1998 Oct; 155(10):1434-6. PMID: 9766777.
    View in: PubMed
  374. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res Dev Brain Res. 1998 Oct 01; 110(2):227-33. PMID: 9748595.
    View in: PubMed
  375. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse. 1998 Oct; 30(2):227-35. PMID: 9723793.
    View in: PubMed
  376. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neurosci Lett. 1998 Sep 18; 254(1):21-4. PMID: 9780082.
    View in: PubMed
  377. Shelton RC, Thase ME, Kowatch R, Baldessarini RJ. Update on the management of bipolar illness. J Clin Psychiatry. 1998 Sep; 59(9):484-95; quiz 496. PMID: 9771823.
    View in: PubMed
  378. Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, Tohen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry. 1998 Aug; 59(8):405-14. PMID: 9721820.
    View in: PubMed
  379. Tarazi FI, Campbell A, Baldessarini RJ. Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors. Neurosci Lett. 1998 Jun 26; 250(1):13-6. PMID: 9696054.
    View in: PubMed
  380. Teicher MH, Andersen SL, Campbell A, Gelbard HA, Baldessarini RJ. Progressive accumbens degeneration after neonatal striatal 6-hydroxydopamine in rats. Neurosci Lett. 1998 May 15; 247(2-3):99-102. PMID: 9655602.
    View in: PubMed
  381. Yeghiayan SK, Gongwer MA, Baldessarini RJ, Kula NS, Zong R, Neumeyer JL. Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites. Brain Res. 1998 May 11; 792(2):324-6. PMID: 9593972.
    View in: PubMed
  382. Tarazi FI, Yeghiayan SK, Neumeyer JL, Baldessarini RJ. Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry. 1998 May; 22(4):693-707. PMID: 9682281.
    View in: PubMed
  383. Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry. 1998 May; 155(5):638-45. PMID: 9585715.
    View in: PubMed
  384. Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry. 1998 Mar-Apr; 5(6):293-306. PMID: 9559348.
    View in: PubMed
  385. Baldessarini RJ, Viguera AC. Medication removal and research in psychotic disorders. Arch Gen Psychiatry. 1998 Mar; 55(3):281-3. PMID: 9510227.
    View in: PubMed
  386. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors. Neuroscience. 1998 Mar; 83(1):169-76. PMID: 9466407.
    View in: PubMed
  387. Baldessarini RJ. The National Institute of Mental Health Career Scientist Awards. Arch Gen Psychiatry. 1998 Jan; 55(1):19-20. PMID: 9435754.
    View in: PubMed
  388. Baldessarini RJ, Tondo L. Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview. Clin Drug Investig. 1998; 15(4):337-51. PMID: 18370489.
    View in: PubMed
  389. George TP, Innamorato L, Sernyak MJ, Baldessarini RJ, Centorrino F. Leukopenia associated with addition of paroxetine to clozapine. J Clin Psychiatry. 1998 Jan; 59(1):31. PMID: 9491066.
    View in: PubMed
  390. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci. 1997 Dec 29; 836:339-51. PMID: 9616808.
    View in: PubMed
  391. Tarazi FI, Kula NS, Baldessarini RJ. Regional distribution of dopamine D4 receptors in rat forebrain. Neuroreport. 1997 Nov 10; 8(16):3423-6. PMID: 9427299.
    View in: PubMed
  392. Yeghiayan SK, Andersen SL, Baldessarini RJ. Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi. Neurosci Lett. 1997 Nov 07; 236(3):147-50. PMID: 9406758.
    View in: PubMed
  393. Campbell A, Villavicencio AT, Yeghiayan SK, Balikian R, Baldessarini RJ. Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Res. 1997 Oct 10; 771(1):55-62. PMID: 9383008.
    View in: PubMed
  394. Tarazi FI, Yeghiayan SK, Baldessarini RJ, Kula NS, Neumeyer JL. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors. Neuropsychopharmacology. 1997 Sep; 17(3):186-96. PMID: 9272485.
    View in: PubMed
  395. Kula NS, Baldessarini RJ, Kebabian JW, Bakthavachalam V, Xu L. RBI-257: a highly potent dopamine D4 receptor-selective ligand. Eur J Pharmacol. 1997 Jul 23; 331(2-3):333-6. PMID: 9274997.
    View in: PubMed
  396. Zarate CA, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M. Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry. 1997 Jul; 58(7):311-7. PMID: 9269252.
    View in: PubMed
  397. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am J Psychiatry. 1997 Jun; 154(6):861-3. PMID: 9167518.
    View in: PubMed
  398. Gardner DM, Baldessarini RJ, Benzo J, Zarate CA, Tohen M. Switching between clozapine and risperidone treatment. Can J Psychiatry. 1997 May; 42(4):430-1. PMID: 9161773.
    View in: PubMed
  399. Tondo L, Baldessarini RJ, Floris G, Rudas N. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry. 1997 Apr; 154(4):548-50. PMID: 9090344.
    View in: PubMed
  400. Bodkin JA, Lasser RA, Wines JD, Gardner DM, Baldessarini RJ. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry. 1997 Apr; 58(4):137-45. PMID: 9164423.
    View in: PubMed
  401. Baldessarini RJ, Tondo L, Floris G, Rudas N. Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study. Am J Psychiatry. 1997 Apr; 154(4):551-3. PMID: 9090345.
    View in: PubMed
  402. Biederman J, Faraone SV, Baldessarini RJ, Flood J, Meyer M, Wilens T, Spencer T, Chen L, Weber W. Predicting desipramine levels in children and adolescents: a naturalistic clinical study. J Am Acad Child Adolesc Psychiatry. 1997 Mar; 36(3):384-9. PMID: 9055519.
    View in: PubMed
  403. Lasser RA, Baldessarini RJ. Thyroid hormones in depressive disorders: a reappraisal of clinical utility. Harv Rev Psychiatry. 1997 Mar-Apr; 4(6):291-305. PMID: 9385007.
    View in: PubMed
  404. Zarate CA, Tohen M, Baraibar G, Zarate SB, Baldessarini RJ. Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993. J Affect Disord. 1997 Mar; 43(1):79-84. PMID: 9127833.
    View in: PubMed
  405. Yeghiayan SK, Kelley AE, Kula NS, Campbell A, Baldessarini RJ. Role of dopamine in behavioral effects of serotonin microinjected into rat striatum. Pharmacol Biochem Behav. 1997 Feb; 56(2):251-9. PMID: 9050082.
    View in: PubMed
  406. Suppes T, Baldessarini RJ, Motohashi N, Tondo L, Viguera AC. Special treatment issues: maintaining and discontinuing psychotropic medications. Mod Probl Pharmacopsychiatry. 1997; 25:235-54. PMID: 9344380.
    View in: PubMed
  407. Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry. 1997 Jan; 54(1):49-55. PMID: 9006400.
    View in: PubMed
  408. Meyer MC, Baldessarini RJ, Goff DC, Centorrino F. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf. 1996 Nov; 15(5):333-46. PMID: 8941495.
    View in: PubMed
  409. Wilens TE, Biederman J, Baldessarini RJ, Geller B, Schleifer D, Spencer TJ, Birmaher B, Goldblatt A. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1996 Nov; 35(11):1491-501. PMID: 8936916.
    View in: PubMed
  410. Baldessarini RJ, Tondo L, Faedda GL, Suppes TR, Floris G, Rudas N. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry. 1996 Oct; 57(10):441-8. PMID: 8909329.
    View in: PubMed
  411. Baldessarini RJ, Suppes T, Tondo L. Lithium Withdrawal in Bipolar Disorder: Implications for Clinical Practice and Experimental Therapeutics Research. Am J Ther. 1996 Jul; 3(7):492-496. PMID: 11862280.
    View in: PubMed
  412. Centorrino F, Baldessarini RJ, Frankenburg FR, Kando J, Volpicelli SA, Flood JG. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry. 1996 Jun; 153(6):820-2. PMID: 8633698.
    View in: PubMed
  413. Baldessarini RJ, Tarazi FI. Brain dopamine receptors: a primer on their current status, basic and clinical. Harv Rev Psychiatry. 1996 Mar-Apr; 3(6):301-25. PMID: 9384962.
    View in: PubMed
  414. Neumeyer JL, Tamagnan G, Wang S, Gao Y, Milius RA, Kula NS, Baldessarini RJ. N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem. 1996 Jan 19; 39(2):543-8. PMID: 8558525.
    View in: PubMed
  415. Baldessarini RJ, Gardner DM, Garver DL. Conversions from clozapine to other antipsychotic drugs. Arch Gen Psychiatry. 1995 Dec; 52(12):1071-2. PMID: 7492259.
    View in: PubMed
  416. Faedda GL, Baldessarini RJ, Suppes T, Tondo L, Becker I, Lipschitz DS. Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry. 1995 Nov-Dec; 3(4):171-95. PMID: 9384947.
    View in: PubMed
  417. Aravagiri M, Marder SR, Yuwiler A, Midha KK, Kula NS, Baldessarini RJ. Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat. Neuropsychopharmacology. 1995 Nov; 13(3):235-47. PMID: 8602896.
    View in: PubMed
  418. Wyrick SD, Booth RG, Myers AM, Owens CE, Bucholtz EC, Hooper PC, Kula NS, Baldessarini RJ, Mailman RB. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships. J Med Chem. 1995 Sep 15; 38(19):3857-64. PMID: 7562917.
    View in: PubMed
  419. Zarate CA, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry. 1995 Sep; 56(9):411-7. PMID: 7665540.
    View in: PubMed
  420. Baldessarini RJ, Kando JC, Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry. 1995 Jul; 152(7):1038-44. PMID: 7793440.
    View in: PubMed
  421. Centorrino F, Baldessarini RJ, Flood JG, Kando JC, Frankenburg FR. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites. Am J Psychiatry. 1995 Apr; 152(4):610-2. PMID: 7694912.
    View in: PubMed
  422. Baldessarini RJ, Viguera AC. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry. 1995 Mar; 52(3):189-92. PMID: 7872842.
    View in: PubMed
  423. Tohen M, Castillo J, Baldessarini RJ, Zarate C, Kando JC. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry. 1995 Mar; 152(3):413-8. PMID: 7864268.
    View in: PubMed
  424. Baldessarini RJ. Risks and implications of interrupting maintenance psychotropic drug therapy. Psychother Psychosom. 1995; 63(3-4):137-41. PMID: 7624457.
    View in: PubMed
  425. Myers AM, Charifson PS, Owens CE, Kula NS, McPhail AT, Baldessarini RJ, Booth RG, Wyrick SD. Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. J Med Chem. 1994 Nov 25; 37(24):4109-17. PMID: 7990111.
    View in: PubMed
  426. Booth RG, Baldessarini RJ, Marsh E, Owens CE. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Brain Res. 1994 Oct 31; 662(1-2):283-8. PMID: 7859086.
    View in: PubMed
  427. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994 Oct; 151(10):1409-16. PMID: 8092334.
    View in: PubMed
  428. Popli AP, Baldessarini RJ, Cole JO. Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. Arch Gen Psychiatry. 1994 Aug; 51(8):666-7. PMID: 8042918.
    View in: PubMed
  429. Baldessarini RJ, Campbell A, Ben-Jonathan N, Ellingboe J, Zong R, Neumeyer JL. Effects of aporphine isomers on rat prolactin. Neurosci Lett. 1994 Aug 01; 176(2):269-71. PMID: 7830962.
    View in: PubMed
  430. Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A, Baldessarini RJ, Zea-Ponce Y, Baldwin RM, Innis RB. N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem. 1994 May 27; 37(11):1558-61. PMID: 8201589.
    View in: PubMed
  431. Baldessarini RJ, Marsh ER, Huston-Lyons D. Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain. Biochem Pharmacol. 1994 May 18; 47(10):1917-9. PMID: 7911303.
    View in: PubMed
  432. Kula NS, Baldessarini RJ, Kebabian JW, Neumeyer JL. S-(+)-aporphines are not selective for human D3 dopamine receptors. Cell Mol Neurobiol. 1994 Apr; 14(2):185-91. PMID: 7842476.
    View in: PubMed
  433. Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol. 1994 Apr; 14(2):119-25. PMID: 8195452.
    View in: PubMed
  434. Baldessarini RJ, Kula NS, Zong R, Neumeyer JL. Receptor affinities of aporphine enantiomers in rat brain tissue. Eur J Pharmacol. 1994 Mar 11; 254(1-2):199-203. PMID: 7911429.
    View in: PubMed
  435. Centorrino F, Baldessarini RJ, Kando J, Frankenburg FR, Volpicelli SA, Puopolo PR, Flood JG. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry. 1994 Jan; 151(1):123-5. PMID: 8267110.
    View in: PubMed
  436. Baldessarini RJ. Enhancing treatment with psychotropic medicines. Bull Menninger Clin. 1994; 58(2):224-41. PMID: 8044132.
    View in: PubMed
  437. Booth RG, Wyrick SD, Baldessarini RJ, Kula NS, Myers AM, Mailman RB. New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies. Mol Pharmacol. 1993 Dec; 44(6):1232-9. PMID: 8264560.
    View in: PubMed
  438. Stoll AL, Tohen M, Baldessarini RJ, Goodwin DC, Stein S, Katz S, Geenens D, Swinson RP, Goethe JW, McGlashan T. Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry. 1993 Nov; 150(11):1668-73. PMID: 8214175.
    View in: PubMed
  439. Teicher MH, Barber NI, Gelbard HA, Gallitano AL, Campbell A, Marsh E, Baldessarini RJ. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology. 1993 Sep; 9(2):147-56. PMID: 8216697.
    View in: PubMed
  440. Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv Rev Psychiatry. 1993 Sep-Oct; 1(3):131-44. PMID: 9384841.
    View in: PubMed
  441. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology. 1993 Sep; 9(2):117-24. PMID: 8216694.
    View in: PubMed
  442. Wyrick SD, Booth RG, Myers AM, Owens CE, Kula NS, Baldessarini RJ, McPhail AT, Mailman RB. Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity. J Med Chem. 1993 Aug 20; 36(17):2542-51. PMID: 8102651.
    View in: PubMed
  443. Baldessarini RJ, Kula NS, McGrath CR, Bakthavachalam V, Kebabian JW, Neumeyer JL. Isomeric selectivity at dopamine D3 receptors. Eur J Pharmacol. 1993 Aug 03; 239(1-3):269-70. PMID: 8223909.
    View in: PubMed
  444. Volpicelli SA, Centorrino F, Puopolo PR, Kando J, Frankenburg FR, Baldessarini RJ, Flood JG. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clin Chem. 1993 Aug; 39(8):1656-9. PMID: 8353952.
    View in: PubMed
  445. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. J Am Acad Child Adolesc Psychiatry. 1993 Jul; 32(4):798-804. PMID: 8340301.
    View in: PubMed
  446. Biederman J, Baldessarini RJ, Goldblatt A, Lapey KA, Doyle A, Hesslein PS. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry. 1993 Jul; 32(4):805-13. PMID: 8340302.
    View in: PubMed
  447. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry. 1993 Jun; 50(6):448-55. PMID: 8498879.
    View in: PubMed
  448. Goff DC, Baldessarini RJ. Drug interactions with antipsychotic agents. J Clin Psychopharmacol. 1993 Feb; 13(1):57-67. PMID: 8098051.
    View in: PubMed
  449. Baldessarini RJ, Cohen BM, Teicher MH. Clinical dosing of neuroleptics. Psychopharmacol Ser. 1993; 10:138-48. PMID: 8103223.
    View in: PubMed
  450. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S. A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. J Am Acad Child Adolesc Psychiatry. 1993 Jan; 32(1):199-204. PMID: 8428872.
    View in: PubMed
  451. Faedda GL, Tondo L, Teicher MH, Baldessarini RJ, Gelbard HA, Floris GF. Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression. Arch Gen Psychiatry. 1993 Jan; 50(1):17-23. PMID: 8422217.
    View in: PubMed
  452. Campbell A, Baldessarini RJ, Neumeyer JL. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine. Psychopharmacology (Berl). 1993; 111(3):351-8. PMID: 7870974.
    View in: PubMed
  453. Baldessarini RJ, Kula NS, Campbell A, Bakthavachalam V, Yuan J, Neumeyer JL. Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain. Mol Pharmacol. 1992 Nov; 42(5):856-63. PMID: 1435753.
    View in: PubMed
  454. Campbell A, Baldessarini RJ, Yeghiayan S. Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat. Brain Res. 1992 Oct 02; 592(1-2):348-52. PMID: 1360315.
    View in: PubMed
  455. Wilens TE, Biederman J, Baldessarini RJ, McDermott SP, Puopolo PR, Flood JG. Fluoxetine inhibits desipramine metabolism. Arch Gen Psychiatry. 1992 Sep; 49(9):752. PMID: 1514882.
    View in: PubMed
  456. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG. Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. J Am Acad Child Adolesc Psychiatry. 1992 Jul; 31(4):691-8. PMID: 1644733.
    View in: PubMed
  457. Baldessarini RJ, Marsh ER, Kula NS. Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Res. 1992 May 01; 579(1):152-6. PMID: 1623401.
    View in: PubMed
  458. Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM. Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry Suppl. 1992 May; (17):12-6. PMID: 1418884.
    View in: PubMed
  459. Stoll AL, Tohen M, Baldessarini RJ. Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry. 1992 May; 149(5):638-40. PMID: 1575254.
    View in: PubMed
  460. Kula NS, George T, Baldessarini RJ. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ). Brain Res Dev Brain Res. 1992 Apr 24; 66(2):286-9. PMID: 1535031.
    View in: PubMed
  461. Neumeyer JL, Kula NS, Baldessarini RJ, Baindur N. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue. J Med Chem. 1992 Apr 17; 35(8):1466-71. PMID: 1533424.
    View in: PubMed
  462. Neumeyer JL, Baindur N, Bakthavachalam V, Yuan J, Madras BK, Kula NS, Campbell A, Baldessarini RJ. Alan Horn Memorial Lecture. Selective probes for characterization of dopamine D1 and D2 receptors. Neurochem Int. 1992 Mar; 20 Suppl:63S-68S. PMID: 1365458.
    View in: PubMed
  463. Cohen BM, Tsuneizumi T, Baldessarini RJ, Campbell A, Babb SM. Differences between antipsychotic drugs in persistence of brain levels and behavioral effects. Psychopharmacology (Berl). 1992; 108(3):338-44. PMID: 1355924.
    View in: PubMed
  464. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991 Dec; 48(12):1082-8. PMID: 1845226.
    View in: PubMed
  465. Teicher MH, Gallitano AL, Gelbard HA, Evans HK, Marsh ER, Booth RG, Baldessarini RJ. Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum. Brain Res Dev Brain Res. 1991 Nov 19; 63(1-2):229-35. PMID: 1686425.
    View in: PubMed
  466. Satlin A, Teicher MH, Lieberman HR, Baldessarini RJ, Volicer L, Rheaume Y. Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology. 1991 Sep; 5(2):115-26. PMID: 1930614.
    View in: PubMed
  467. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C. Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry. 1991 Sep; 148(9):1237-9. PMID: 1883005.
    View in: PubMed
  468. Booth RG, Baldessarini RJ. (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res. 1991 Aug 23; 557(1-2):349-52. PMID: 1684130.
    View in: PubMed
  469. Booth RG, Baldessarini RJ, Campbell A. Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine. Biochem Pharmacol. 1991 Jun 15; 41(12):2040-3. PMID: 1674873.
    View in: PubMed
  470. Goff DC, Midha KK, Brotman AW, Waites M, Baldessarini RJ. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. Am J Psychiatry. 1991 Jun; 148(6):790-2. PMID: 2035723.
    View in: PubMed
  471. Baldessarini RJ, Frankenburg FR. Clozapine. A novel antipsychotic agent. N Engl J Med. 1991 Mar 14; 324(11):746-54. PMID: 1671793.
    View in: PubMed
  472. Baldessarini RJ, Kula NS, Gao Y, Campbell A, Neumeyer JL. R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist. Neuropharmacology. 1991 Jan; 30(1):97-9. PMID: 1675452.
    View in: PubMed
  473. Neumeyer JL, Gao YG, Kula NS, Baldessarini RJ. R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue. J Med Chem. 1991 Jan; 34(1):24-8. PMID: 1671415.
    View in: PubMed
  474. Kula NS, Baldessarini RJ. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology. 1991 Jan; 30(1):89-92. PMID: 2046881.
    View in: PubMed
  475. Campbell A, Yeghiayan S, Baldessarini RJ, Neumeyer JL. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents. Psychopharmacology (Berl). 1991; 103(3):323-9. PMID: 1676180.
    View in: PubMed
  476. Nemeroff CB, Kilts CD, Levant B, Bissette G, Campbell A, Baldessarini RJ. Effects of the isomers of N-n-propylnorapomorphine and haloperidol on regional concentrations of neurotensin in rat brain. Neuropsychopharmacology. 1991 Jan; 4(1):27-33. PMID: 1672249.
    View in: PubMed
  477. Neumeyer JL, Gao YG, Kula NS, Baldessarini RJ. Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist. J Med Chem. 1990 Dec; 33(12):3122-4. PMID: 2147956.
    View in: PubMed
  478. Gelbard HA, Teicher MH, Baldessarini RJ, Gallitano A, Marsh ER, Zorc J, Faedda G. Dopamine D1 receptor development depends on endogenous dopamine. Brain Res Dev Brain Res. 1990 Oct 01; 56(1):137-40. PMID: 2149085.
    View in: PubMed
  479. Booth RG, Baldessarini RJ. Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation. Eur J Pharmacol. 1990 Aug 28; 185(2-3):217-21. PMID: 1979274.
    View in: PubMed
  480. Baldessarini RJ, Marsh ER, Kula NS, Zong RS, Gao YG, Neumeyer JL. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Biochem Pharmacol. 1990 Aug 01; 40(3):417-23. PMID: 2383279.
    View in: PubMed
  481. Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Mol Pharmacol. 1990 Jul; 38(1):92-101. PMID: 1973525.
    View in: PubMed
  482. Campbell A, Baldessarini RJ, Gao Y, Zong R, Neumeyer JL. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat. Neuropharmacology. 1990 Jun; 29(6):527-36. PMID: 1974710.
    View in: PubMed
  483. Gao YG, Baldessarini RJ, Kula NS, Neumeyer JL. Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues. J Med Chem. 1990 Jun; 33(6):1800-5. PMID: 1971309.
    View in: PubMed
  484. Gelenberg AJ, Wojcik JD, Falk WE, Baldessarini RJ, Zeisel SH, Schoenfeld D, Mok GS. Tyrosine for depression: a double-blind trial. J Affect Disord. 1990 Jun; 19(2):125-32. PMID: 2142699.
    View in: PubMed
  485. Baldessarini RJ, Marsh E. Fluoxetine and side effects. Arch Gen Psychiatry. 1990 Feb; 47(2):191-2. PMID: 2105706.
    View in: PubMed
  486. Gao YG, Ram VJ, Campbell A, Kula NS, Baldessarini RJ, Neumeyer JL. Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain. J Med Chem. 1990 Jan; 33(1):39-44. PMID: 2136919.
    View in: PubMed
  487. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A. A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry. 1989 Nov; 28(6):903-11. PMID: 2808261.
    View in: PubMed
  488. Keck PE, Cohen BM, Baldessarini RJ, McElroy SL. Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry. 1989 Oct; 146(10):1289-92. PMID: 2571305.
    View in: PubMed
  489. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiatry. 1989 Sep; 28(5):777-84. PMID: 2676967.
    View in: PubMed
  490. Campbell A, Baldessarini RJ, Cremens C, Teicher MH, Marsh E, Kula NS. Bromocriptine antagonizes behavioral effects of cocaine in the rat. Neuropsychopharmacology. 1989 Sep; 2(3):209-24. PMID: 2789660.
    View in: PubMed
  491. Gelbard HA, Teicher MH, Faedda G, Baldessarini RJ. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Brain Res Dev Brain Res. 1989 Sep 01; 49(1):123-30. PMID: 2529061.
    View in: PubMed
  492. Cohen BM, Benes FM, Baldessarini RJ. Atypical neuroleptics, dose-response relationships, and treatment-resistant psychosis. Arch Gen Psychiatry. 1989 Apr; 46(4):381-3. PMID: 2564764.
    View in: PubMed
  493. Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry. 1989 Apr; 50(4):117-26. PMID: 2647712.
    View in: PubMed
  494. Faedda G, Kula NS, Baldessarini RJ. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem Pharmacol. 1989 Feb 01; 38(3):473-80. PMID: 2563653.
    View in: PubMed
  495. Barber NI, Teicher MH, Baldessarini RJ. Effects of selective monoaminergic reuptake blockade on activity rhythms in developing rats. Psychopharmacology (Berl). 1989; 97(3):343-8. PMID: 2497483.
    View in: PubMed
  496. Trainor TM, Vouros P, Lampen P, Neumeyer JL, Baldessarini RJ, Kula NS. Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry. J Chromatogr. 1988 Dec 21; 457:257-66. PMID: 3243885.
    View in: PubMed
  497. Teicher MH, Cohen BM, Baldessarini RJ, Cole JO. Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry. 1988 Dec; 145(12):1552-6. PMID: 3273886.
    View in: PubMed
  498. Campbell A, Baldessarini RJ, Cremens MC. Dose-catalepsy response to haloperidol in rat: effects of strain and sex. Neuropharmacology. 1988 Nov; 27(11):1197-9. PMID: 3205387.
    View in: PubMed
  499. Svendsen CN, Froimowitz M, Hrbek C, Campbell A, Kula N, Baldessarini RJ, Cohen BM, Babb S, Teicher MH, Bird ED. Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology. 1988 Nov; 27(11):1117-24. PMID: 2849726.
    View in: PubMed
  500. Teicher MH, Lawrence JM, Barber NI, Finklestein SP, Lieberman HR, Baldessarini RJ. Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations. Arch Gen Psychiatry. 1988 Oct; 45(10):913-7. PMID: 3421804.
    View in: PubMed
  501. Baldessarini RJ, Teicher MH, Cassidy JW, Stein MH. Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs. J Clin Psychopharmacol. 1988 Oct; 8(5):381-2. PMID: 3183079.
    View in: PubMed
  502. Baldessarini RJ. A summary of current knowledge of tardive dyskinesia. Encephale. 1988 Sep; 14 Spec No:263-8. PMID: 2905654.
    View in: PubMed
  503. Cohen BM, Babb S, Campbell A, Baldessarini RJ. Persistence of haloperidol in the brain. Arch Gen Psychiatry. 1988 Sep; 45(9):879-80. PMID: 3415432.
    View in: PubMed
  504. Gutierrez-Esteinou R, Baldessarini RJ, Cremens MC, Campbell A, Teicher MH. Interactions of bromocriptine with cocaine. Am J Psychiatry. 1988 Sep; 145(9):1173. PMID: 3414860.
    View in: PubMed
  505. Arana GW, Goff DC, Baldessarini RJ, Keepers GA. Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. Am J Psychiatry. 1988 Aug; 145(8):993-6. PMID: 2899403.
    View in: PubMed
  506. Gao Y, Zong R, Campbell A, Kula NS, Baldessarini RJ, Neumeyer JL. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine. J Med Chem. 1988 Jul; 31(7):1392-6. PMID: 3385732.
    View in: PubMed
  507. Baldessarini RJ, Vogt M. Release of 3H-dopamine and analogous monoamines from rat striatal tissue. Cell Mol Neurobiol. 1988 Jun; 8(2):205-16. PMID: 3409267.
    View in: PubMed
  508. Lampen P, Neumeyer JL, Baldessarini RJ. High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma. J Chromatogr. 1988 Apr 29; 426(2):283-94. PMID: 3392141.
    View in: PubMed
  509. Teicher MH, Barber NI, Baldessarini RJ, Shaywitz BA. Amphetamine accelerates and attenuates ultradian activity rhythms in preweanling rats. Pharmacol Biochem Behav. 1988 Mar; 29(3):517-23. PMID: 3362945.
    View in: PubMed
  510. Kula NS, Baldessarini RJ, Murphy F, Neumeyer JL. Substituted phenylpiperidines and phenylpyridines as reversible selective inhibitors of monoamine oxidase type A in rodent brain and liver. Biochem Pharmacol. 1988 Feb 15; 37(4):763-6. PMID: 3257699.
    View in: PubMed
  511. Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry. 1988 Jan; 45(1):79-91. PMID: 2892478.
    View in: PubMed
  512. Neumeyer JL, Froimowitz M, Baldessarini RJ, Campbell A, Gao YG. Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs. J Recept Res. 1988; 8(1-4):83-96. PMID: 3385694.
    View in: PubMed
  513. Baldessarini RJ, Tohen M. Is there a long-term protective effect of mood-altering agents in unipolar depressive disorder? Psychopharmacol Ser. 1988; 5:130-9. PMID: 3045797.
    View in: PubMed
  514. Campbell A, Baldessarini RJ, Teicher MH. Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor. Psychopharmacology (Berl). 1988; 94(1):46-51. PMID: 2894702.
    View in: PubMed
  515. Baldessarini RJ. Neuropharmacology of S-adenosyl-L-methionine. Am J Med. 1987 Nov 20; 83(5A):95-103. PMID: 3318448.
    View in: PubMed
  516. Finklestein SP, Weintraub RJ, Karmouz N, Askinazi C, Davar G, Baldessarini RJ. Antidepressant drug treatment for poststroke depression: retrospective study. Arch Phys Med Rehabil. 1987 Nov; 68(11):772-6. PMID: 3675174.
    View in: PubMed
  517. Froimowitz M, Baldessarini RJ. A stereochemical and conformational model of dopaminergic agonist and antagonist activity: further evaluation. J Pharm Sci. 1987 Jul; 76(7):557-64. PMID: 3668819.
    View in: PubMed
  518. Lamont JS, Kula NS, Baldessarini RJ. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue. Neuropharmacology. 1987 Jun; 26(6):637-9. PMID: 3601010.
    View in: PubMed
  519. Campbell A, Baldessarini RJ, Kula NS, Ram VJ, Neumeyer JL. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system. Brain Res. 1987 Feb 17; 403(2):393-7. PMID: 3828830.
    View in: PubMed
  520. Baldessarini RJ, Kula NS, Francoeur D, Finklestein SP, Murphy F, Neumeyer JL. Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue. Life Sci. 1986 Nov 10; 39(19):1765-77. PMID: 3490612.
    View in: PubMed
  521. Teicher MH, Barber NI, Reichheld JH, Baldessarini RJ, Finklestein SP. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat. Brain Res. 1986 Nov; 395(1):124-8. PMID: 2430678.
    View in: PubMed
  522. Froimowitz M, Neumeyer JL, Baldessarini RJ. A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs. J Med Chem. 1986 Sep; 29(9):1570-3. PMID: 3746808.
    View in: PubMed
  523. Baldessarini RJ, Cohen BM. Regulation of psychiatric practice. Am J Psychiatry. 1986 Jun; 143(6):750-1. PMID: 3717398.
    View in: PubMed
  524. Baldessarini RJ, Kula NS, Francoeur D, Finklestein SP. Antioxidants fail to inhibit depletion of striatal dopamine by MPTP. Neurology. 1986 May; 36(5):735. PMID: 3486381.
    View in: PubMed
  525. Baldessarini RJ, Neumeyer JL. Lack of depletion of striatal dopamine by phenylpiperidine analgesics. N Engl J Med. 1986 Mar 06; 314(10):649. PMID: 3484802.
    View in: PubMed
  526. Biederman J, Baldessarini RJ, Harmatz JS, Rivinus TM, Arana GW, Herzog DB, Schildkraut JJ. Heterogeneity in anorexia nervosa. Biol Psychiatry. 1986 Feb; 21(2):213-6. PMID: 3004610.
    View in: PubMed
  527. Campbell A, Baldessarini RJ, Teicher MH, Neumeyer JL. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine. Psychopharmacology (Berl). 1986; 88(2):158-64. PMID: 3081927.
    View in: PubMed
  528. Teicher MH, Lawrence JM, Barber NI, Finklestein SP, Lieberman H, Baldessarini RJ. Altered locomotor activity in neuropsychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 1986; 10(6):755-61. PMID: 3809527.
    View in: PubMed
  529. Arana GW, Baldessarini RJ, Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry. 1985 Dec; 42(12):1193-204. PMID: 3000317.
    View in: PubMed
  530. Finklestein S, Campbell A, Baldessarini RJ, Moya KL, Haber SN. Late changes in cerebral monoamine metabolism following focal ventrolateral cerebrocortical lesions in rats. Brain Res. 1985 Oct 07; 344(2):205-10. PMID: 2412650.
    View in: PubMed
  531. Kula NS, Baldessarini RJ, Bromley S, Neumeyer JL. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. Life Sci. 1985 Sep 16; 37(11):1051-7. PMID: 4033350.
    View in: PubMed
  532. Teicher MH, Baldessarini RJ. Selection of neuroleptic dosage. Arch Gen Psychiatry. 1985 Jun; 42(6):636-7. PMID: 2860885.
    View in: PubMed
  533. Campbell A, Baldessarini RJ. Prolonged pharmacologic activity of neuroleptics. Arch Gen Psychiatry. 1985 Jun; 42(6):637. PMID: 2860886.
    View in: PubMed
  534. Campbell A, Baldessarini RJ, Teicher MH, Neumeyer JL. S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat. Neuropharmacology. 1985 May; 24(5):391-9. PMID: 4022264.
    View in: PubMed
  535. Cohen BM, Baldessarini RJ. Tolerance to therapeutic effects of antidepressants. Am J Psychiatry. 1985 Apr; 142(4):489-90. PMID: 3976923.
    View in: PubMed
  536. Baldessarini RJ. Clinical and epidemiologic aspects of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):8-13. PMID: 2858483.
    View in: PubMed
  537. Baldessarini RJ, Arana GW. Does the dexamethasone suppression test have clinical utility in psychiatry? J Clin Psychiatry. 1985 Feb; 46(2 Pt 2):25-9. PMID: 3968053.
    View in: PubMed
  538. Arana GW, Wilens TE, Baldessarini RJ. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients. Psychoneuroendocrinology. 1985; 10(1):49-60. PMID: 4001277.
    View in: PubMed
  539. Jacob JN, Shashoua VE, Campbell A, Baldessarini RJ. gamma-Aminobutyric acid esters. 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of gamma-aminobutyric acid. J Med Chem. 1985 Jan; 28(1):106-10. PMID: 3965703.
    View in: PubMed
  540. Campbell A, Baldessarini RJ, Teicher MH, Kula NS. Prolonged antidopaminergic actions of single doses of butyrophenones in the rat. Psychopharmacology (Berl). 1985; 87(2):161-6. PMID: 3931140.
    View in: PubMed
  541. Arana GW, Workman RJ, Baldessarini RJ. Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry. 1984 Dec; 141(12):1619-20. PMID: 6507668.
    View in: PubMed
  542. Majocha R, Baldessarini RJ. Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic. Life Sci. 1984 Nov 26; 35(22):2247-55. PMID: 6503612.
    View in: PubMed
  543. Arana GW, Lamont JS, Baldessarini RJ, Teicher MH, Neumeyer JL, Cohen BM. Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus. Neuropharmacology. 1984 Aug; 23(8):885-92. PMID: 6483116.
    View in: PubMed
  544. Campbell A, Baldessarini RJ, Stoll A, Teicher MH, Maynard P. Effect of age on behavioral responses and tissue levels of apomorphine in the rat. Neuropharmacology. 1984 Jul; 23(7A):725-30. PMID: 6540844.
    View in: PubMed
  545. Kula NS, Baldessarini RJ, Campbell A, Finklestein S, Ram VJ, Neumeyer JL. Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species. Life Sci. 1984 Jun 25; 34(26):2567-75. PMID: 6610812.
    View in: PubMed
  546. Baldessarini RJ, Katz B, Cotton P. Dissimilar dosing with high-potency and low-potency neuroleptics. Am J Psychiatry. 1984 Jun; 141(6):748-52. PMID: 6145357.
    View in: PubMed
  547. Stoll AL, Baldessarini RJ, Cohen BM, Finklestein SP. Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection. J Chromatogr. 1984 May 11; 307(2):457-63. PMID: 6736194.
    View in: PubMed
  548. Shashoua VE, Jacob JN, Ridge R, Campbell A, Baldessarini RJ. Gamma-aminobutyric acid esters. 1. Synthesis, brain uptake, and pharmacological studies of aliphatic and steroid esters of gamma-aminobutyric acid. J Med Chem. 1984 May; 27(5):659-64. PMID: 6716404.
    View in: PubMed
  549. Tarsy D, Baldessarini RJ. Tardive dyskinesia. Annu Rev Med. 1984; 35:605-23. PMID: 6144288.
    View in: PubMed
  550. Baldessarini RJ. Risk rates for depression. Arch Gen Psychiatry. 1984 Jan; 41(1):103-6. PMID: 6691778.
    View in: PubMed
  551. Baldessarini RJ. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol Bull. 1984; 20(2):224-39. PMID: 6728992.
    View in: PubMed
  552. Arana GW, Baldessarini RJ, Lamont JS, Amlicke D, Neumeyer JL. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue. Biochem Pharmacol. 1983 Oct 01; 32(19):2873-80. PMID: 6626260.
    View in: PubMed
  553. Akiskal HS, Arana GW, Baldessarini RJ, Barreira PJ. A clinical report of thymoleptic-responsive atypical paranoid psychoses. Am J Psychiatry. 1983 Sep; 140(9):1187-90. PMID: 6614226.
    View in: PubMed
  554. Baldessarini RJ, Kula NS. Irreversible binding of [3H](-)N-chloroethylnorapomorphine to mammalian brain tissue. Life Sci. 1983 Aug 22; 33(8):769-78. PMID: 6193387.
    View in: PubMed
  555. Finklestein S, Campbell A, Stoll AL, Baldessarini RJ, Stinus L, Paskevitch PA, Domesick VB. Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat. Brain Res. 1983 Jul 25; 271(2):279-88. PMID: 6193832.
    View in: PubMed
  556. Baldessarini RJ, Finklestein S, Arana GW. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry. 1983 May; 40(5):569-73. PMID: 6838334.
    View in: PubMed
  557. Neumeyer JL, Reischig D, Arana GW, Campbell A, Baldessarini RJ, Kula NS, Watling KJ. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors. J Med Chem. 1983 Apr; 26(4):516-21. PMID: 6682147.
    View in: PubMed
  558. Wilens TE, Arana GW, Baldessarini RJ, Cremens C. Comparison of solid-phase radioimmunoassay and competitive protein binding method for postdexamethasone cortisol levels in psychiatric patients. Psychiatry Res. 1983 Mar; 8(3):199-206. PMID: 6574539.
    View in: PubMed
  559. Arana GW, Baldessarini RJ. Dexamethasone suppression test. J Clin Psychiatry. 1983 Mar; 44(3):116-7. PMID: 6833191.
    View in: PubMed
  560. Donaldson SR, Gelenberg AJ, Baldessarini RJ. The pharmacologic treatment of schizophrenia: a progress report. Schizophr Bull. 1983; 9(4):504-27. PMID: 6140750.
    View in: PubMed
  561. Sperk G, Campbell A, Baldessarini RJ, Stoll A, Neumeyer JL. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors. Neuropharmacology. 1982 Dec; 21(12):1311-6. PMID: 6891445.
    View in: PubMed
  562. Finklestein S, Benowitz LI, Baldessarini RJ, Arana GW, Levine D, Woo E, Bear D, Moya K, Stoll AL. Mood, vegetative disturbance, and dexamethasone suppression test after stroke. Ann Neurol. 1982 Nov; 12(5):463-8. PMID: 6960804.
    View in: PubMed
  563. Campbell A, Baldessarini RJ, Ram VJ, Neumeyer JL. Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines. Neuropharmacology. 1982 Oct; 21(10):953-61. PMID: 6890636.
    View in: PubMed
  564. Neumeyer JL, Arana GW, Ram VJ, Kula NS, Baldessarini RJ. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine. J Med Chem. 1982 Aug; 25(8):990-2. PMID: 7120288.
    View in: PubMed
  565. Campbell A, Herschel M, Sommer B, Madsen JR, Cohen BM, Baldessarini RJ. Circadian changes in the destruction and effects of haloperidol in the rat. Neuropharmacology. 1982 Jul; 21(7):663-9. PMID: 6889690.
    View in: PubMed
  566. Arana GW, Baldessarini RJ, Kula NS. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes. Neuropharmacology. 1982 Jun; 21(6):601-4. PMID: 6810198.
    View in: PubMed
  567. Law SJ, Morgan JM, Masten LW, Borne RF, Arana GW, Kula NS, Baldessarini RJ. Rigid analogues of dopamine: synthesis and interaction of 6-exo- and 6-endo-(3',4'-dihydroxyphenyl)-2-azabicyclo[2.2.2]octanes with dopamine uptake sites and receptors. J Med Chem. 1982 Mar; 25(3):213-6. PMID: 7069700.
    View in: PubMed
  568. Baldessarini RJ, Neumeyer JL, Campbell A, Sperk G, Ram VJ, Arana GW, Kula NS. An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine. Eur J Pharmacol. 1982 Jan 08; 77(1):87-8. PMID: 6277658.
    View in: PubMed
  569. Campbell A, Baldessarini RJ. Circadian changes in behavioral effects of haloperidol in rats. Psychopharmacology (Berl). 1982; 77(2):150-5. PMID: 6812132.
    View in: PubMed
  570. Majocha RE, Pearse RN, Baldessarini RJ, Delong GR, Walton KG. The noradrenergic system in cultured aggregates of fetal rat brain cells: morphology of the aggregates and pharmacological indices of noradrenergic neurons. Brain Res. 1981 Dec 28; 230(1-2):235-52. PMID: 6274477.
    View in: PubMed
  571. Arana GW, Baldessarini RJ, Harding M. Pharmacology of [3H]apomorphine binding to bovine brain tissue. Biochem Pharmacol. 1981 Dec 01; 30(23):3171-9. PMID: 7317102.
    View in: PubMed
  572. Neumeyer JL, Arana GW, Law SJ, Lamont JS, Kula NS, Baldessarini RJ. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines. J Med Chem. 1981 Dec; 24(12):1440-5. PMID: 7310821.
    View in: PubMed
  573. Cohen BM, Baldessarini RJ. Haloperidol levels and clinical response. Am J Psychiatry. 1981 Nov; 138(11):1513-4. PMID: 7294231.
    View in: PubMed
  574. Madsen JR, Campbell A, Baldessarini RJ. Effects of prenatal treatment of rats with haloperidol due to altered drug distribution in neonatal brain. Neuropharmacology. 1981 Oct; 20(10):931-9. PMID: 7197761.
    View in: PubMed
  575. Campbell A, Baldessarini RJ. Tolerance to behavioral effects of haloperidol. Life Sci. 1981 Sep 28; 29(13):1341-6. PMID: 7197320.
    View in: PubMed
  576. Baldessarini RJ, Lipinski JF. Risks of antipsychotic drugs overemphasized. N Engl J Med. 1981 Sep 03; 305(10):588-9. PMID: 6114430.
    View in: PubMed
  577. Arana GW, Baldessarini RJ, Herschel M, Fava M. Improved high-affinity binding of 3H-apomorphine with a subcellular membrane fraction of mammalian brain tissue. Life Sci. 1981 Jul 13; 29(2):121-33. PMID: 6270486.
    View in: PubMed
  578. Wolfe BB, Augustyn DH, Majocha RE, Dibner MD, Molinoff PB, Baldessarini RJ, Walton KG. Effects of isoproterenol on the development of beta-adrenergic receptors in brain cell aggregates. Brain Res. 1981 Feb 23; 207(1):174-7. PMID: 6258728.
    View in: PubMed
  579. Campbell A, Baldessarini RJ. Effects of maturation and aging on behavioral responses to haloperidol in the rat. Psychopharmacology (Berl). 1981; 73(3):219-22. PMID: 6787640.
    View in: PubMed
  580. Smith JM, Baldessarini RJ. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry. 1980 Dec; 37(12):1368-73. PMID: 6108750.
    View in: PubMed
  581. Gerson SC, Baldessarini RJ. Motor effects of serotonin in the central nervous system. Life Sci. 1980 Oct 20; 27(16):1435-51. PMID: 6160367.
    View in: PubMed
  582. Majocha R, Baldessarini RJ. Increased muscarinic receptor binding in rat forebrain after scopolamine. Eur J Pharmacol. 1980 Oct 17; 67(2-3):327-8. PMID: 7461037.
    View in: PubMed
  583. Campbell A, Kula NS, Jeppsson B, Baldessarini RJ. Oral bioavailability of apomorphine in the rat with a portacaval venous anastomosis. Eur J Pharmacol. 1980 Oct 03; 67(1):139-42. PMID: 7191371.
    View in: PubMed
  584. Baldessarini RJ, Kula NS, Arana GW, Neumeyer JL, Law SJ. Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro. Eur J Pharmacol. 1980 Oct 03; 67(1):105-10. PMID: 7418727.
    View in: PubMed
  585. Baldessarini RJ, Davis JM. What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatry Res. 1980 Oct; 3(2):115-22. PMID: 6118906.
    View in: PubMed
  586. Mandel MR, Madsen J, Miller AL, Baldessarini RJ. Intoxication associated with lithium and ECT. Am J Psychiatry. 1980 Sep; 137(9):1107-9. PMID: 7425167.
    View in: PubMed
  587. Campbell A, Herschel M, Cohen BM, Baldessarini RJ. Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat. Life Sci. 1980 Aug 25; 27(8):633-40. PMID: 7191037.
    View in: PubMed
  588. Cohen BM, Herschel M, Miller E, Mayberg H, Baldessarini RJ. Radioreceptor assay of haloperidol tissue levels in the rat. Neuropharmacology. 1980 Jul; 19(7):663-8. PMID: 7402454.
    View in: PubMed
  589. Neumeyer JL, Law SJ, Baldessarini RJ, Kula NS. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist. J Med Chem. 1980 Jun; 23(6):594-5. PMID: 7392026.
    View in: PubMed
  590. Warbritton JD, Stewart RM, Baldessarini RJ. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine. Brain Res. 1980 Feb 10; 183(2):355-66. PMID: 6153283.
    View in: PubMed
  591. Baldessarini RJ, Tarsy D. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu Rev Neurosci. 1980; 3:23-41. PMID: 6106450.
    View in: PubMed
  592. Baldessarini RJ, Tarsy D. Pathophysiologic basis of tardive dyskinesia. Adv Biochem Psychopharmacol. 1980; 24:451-5. PMID: 6105793.
    View in: PubMed
  593. Baldessarini RJ, Gelenberg AJ. Using physostigmine safely. Am J Psychiatry. 1979 Dec; 136(12):1608-9. PMID: 507223.
    View in: PubMed
  594. Walton KG, Miller E, Baldessarini RJ. Prenatal and early postnatal beta-adrenergic receptor-mediated increase of cyclic AMP in slices of rat brain. Brain Res. 1979 Nov 30; 177(3):515-22. PMID: 91411.
    View in: PubMed
  595. Baldessarini RJ. Status of psychotropic drug blood level assays and other biochemical measurements in clinical practice. Am J Psychiatry. 1979 Sep; 136(9):1177-80. PMID: 38674.
    View in: PubMed
  596. Smith RV, Wilcox RE, Soine WH, Riffee WH, Baldessarini RJ, Kula NS. Plasma levels of apomorphine following intravenous, intraperitoneal and oral administration to mice and rats. Res Commun Chem Pathol Pharmacol. 1979 Jun; 24(3):483-99. PMID: 582213.
    View in: PubMed
  597. Baldessarini RJ, Kula NS, Walton KG. Effects of alternative transmitter amines on cyclic AMP formation in rat brain tissue. Eur J Pharmacol. 1979 Jun; 56(1-2):167-71. PMID: 38128.
    View in: PubMed
  598. Herschel M, Baldessarini RJ. Evidence for two types of binding of 3H-gaba and 3H-muscimol in rat cerebral cortex and cerebellum. Life Sci. 1979 May 14; 24(20):1849-54. PMID: 459687.
    View in: PubMed
  599. Baldessarini RJ. The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action. Postgrad Med. 1979 Apr; 65(4):108-11, 114-9. PMID: 34141.
    View in: PubMed
  600. Baldessarini RJ. The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects. Postgrad Med. 1979 Apr; 65(4):123-8. PMID: 34142.
    View in: PubMed
  601. Baldessarini RJ, Stramentinoli G, Lipinski JF. Methylation hypothesis. Arch Gen Psychiatry. 1979 Mar; 36(3):303-7. PMID: 420548.
    View in: PubMed
  602. Stewart RM, Campbell A, Sperk G, Baldessarini RJ. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat. Psychopharmacology (Berl). 1979 Feb 28; 60(3):281-9. PMID: 108706.
    View in: PubMed
  603. Baldessarini RJ, Tarsy D. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int Rev Neurobiol. 1979; 21:1-45. PMID: 43842.
    View in: PubMed
  604. Baldessarini RJ, Boyd AE, Kula NS, Borgman RJ. Prolonged decrease of serum prolactin in rat by an ester prodrug of apomorphine. Psychoneuroendocrinology. 1979; 4(2):173-5. PMID: 523586.
    View in: PubMed
  605. Sperk G, Stewart RM, Campbell A, Baldessarini RJ. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide. Brain Res. 1978 Dec 22; 159(1):183-94. PMID: 310331.
    View in: PubMed
  606. Walton KG, Liepmann P, Baldessarini RJ. Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine. Eur J Pharmacol. 1978 Nov 15; 52(2):231-4. PMID: 729635.
    View in: PubMed
  607. Stramentinoli G, Baldessarini RJ. Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine or S-adenosylmethionine. J Neurochem. 1978 Oct; 31(4):1015-20. PMID: 279646.
    View in: PubMed
  608. Baldessarini RJ. The pathophysiologic basis of tardive dyskinesia. Psychopharmacol Bull. 1978 Oct; 14(4):79-81. PMID: 30114.
    View in: PubMed
  609. Groshong R, Baldessarini RJ, Gibson DA, Lipinski JF, Axelrod D, Pope A. Activities of types A and B MAO and catechol-o-methyltransferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects. Arch Gen Psychiatry. 1978 Oct; 35(10):1198-1205. PMID: 697538.
    View in: PubMed
  610. Stewart RM, Gerson SC, Sperk G, Campbell A, Baldessarini RJ. Biochemical, behavioral, and pharmacologic studies of the effects of dihydroxytryptamines in the rodent brain. Ann N Y Acad Sci. 1978 Jun 12; 305:198-207. PMID: 309297.
    View in: PubMed
  611. Warbritton JD, Stewart RM, Baldessarini RJ. Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Res. 1978 Mar 24; 143(2):373-82. PMID: 630415.
    View in: PubMed
  612. Baldessarini RJ. Trace amines and alternative neurotransmitters in the central nervous system. Biochem Pharmacol. 1978 Mar 01; 27(5):621-6. PMID: 26346.
    View in: PubMed
  613. Noon JP, Rice PJ, Baldessarini RJ. Calcium leakage as a cause of the high resting tension in vascular smooth muscle from the spontaneously hypertensive rat. Proc Natl Acad Sci U S A. 1978 Mar; 75(3):1605-7. PMID: 274745; PMCID: PMC411523.
  614. Baldessarini RJ. On the development and utilization of assays for biological transmethylation involving S-adenosylmethionine. Monogr Gesamtgeb Psychiatr Psychiatry Ser. 1978; 18:31-48. PMID: 29217.
    View in: PubMed
  615. Ducomb L, Baldessarini RJ. Timing and risk of bone marrow depression by psychotropic drugs. Am J Psychiatry. 1977 Nov; 134(11):1294-5. PMID: 910989.
    View in: PubMed
  616. Baldessarini RJ. Mood drugs. Dis Mon. 1977 Nov; 24(2):1-65. PMID: 21061.
    View in: PubMed
  617. Groshong R, Gibson DA, Baldessarini RJ. Monoamine oxidase activity in cultured human skin fibroblasts. Clin Chim Acta. 1977 Oct 01; 80(1):113-20. PMID: 908136.
    View in: PubMed
  618. Baldessarini RJ, Kula NS, Walton KG, Borgman RJ. Hydrolysis of diester prodrugs of apomorphine. Biochem Pharmacol. 1977 Oct 01; 26(19):1749-56. PMID: 907714.
    View in: PubMed
  619. Baldessarini RJ, Fischer JE. Substitute and alternative neurotransmitters in neuropsychiatric illness. Arch Gen Psychiatry. 1977 Aug; 34(8):958-64. PMID: 19004.
    View in: PubMed
  620. Baldessarini RJ, Kula NS, Walton KG. Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse. Psychopharmacology (Berl). 1977 Jun 06; 53(1):45-53. PMID: 407613.
    View in: PubMed
  621. Sperk G, Baldessarini RJ. Stabilizing effect of sucrose on leakage of cytoplasm from rat brain synaptosomes in saline media. J Neurochem. 1977 Jun; 28(6):1403-5. PMID: 874506.
    View in: PubMed
  622. Tarsy D, Baldessarini RJ. The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry. 1977 Jun; 12(3):431-50. PMID: 194633.
    View in: PubMed
  623. Stewart RM, Martuza RL, Baldessarini RJ, Kornblith PL. Glutamate accumulation by human gliomas and meningiomas in tissue culture. Brain Res. 1976 Dec 24; 118(3):441-52. PMID: 1009428.
    View in: PubMed
  624. Walton KG, Baldessarini RJ. Effects of Mn2+ and other divalent cations on adenylate cyclase activity in rat brain. J Neurochem. 1976 Aug; 27(2):557-64. PMID: 184249.
    View in: PubMed
  625. Stewart RM, Growdon JH, Cancian D, Baldessarini RJ. 5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacology. 1976 Aug; 15(8):449-55. PMID: 1086442.
    View in: PubMed
  626. Baldessarini RJ, Griffith FF. Acute increases by p-chlorophenylalanine of apomorphine-induced stereotyped behavior in the rat. Psychopharmacology (Berl). 1976 Jul 09; 48(1):91-5. PMID: 135269.
    View in: PubMed
  627. Stewart RM, Growdon JH, Cancian D, Baldessarini RJ. Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system. Neurology. 1976 Jul; 26(7):690-2. PMID: 1084496.
    View in: PubMed
  628. Borgman RJ, Baldessarini RJ, Walton KG. Diester derivatives as apomorphine prodrugs. J Med Chem. 1976 May; 19(5):717-9. PMID: 944786.
    View in: PubMed
  629. Granacher RP, Baldessarini RJ, Messner E. Physostigmine treatment of delirium induced by anticholinergics. Am Fam Physician. 1976 May; 13(5):99-103. PMID: 1274812.
    View in: PubMed
  630. Baldessarini RJ, Gelenberg AJ, Lipinski JF. Letter: Grams of antipsychotics? N Engl J Med. 1976 Jan 08; 294(2):113-4. PMID: 615.
    View in: PubMed
  631. Baldessarini RJ, Tarsy D. Mechanisms underlying tardive dyskinesia. Res Publ Assoc Res Nerv Ment Dis. 1976; 55:433-46. PMID: 826999.
    View in: PubMed
  632. Fischer JE, Baldessarini RJ. Pathogenesis and therapy of hepatic coma. Prog Liver Dis. 1976; 5:363-97. PMID: 5747.
    View in: PubMed
  633. Harris JE, Karobath M, Baldessarini RJ. Characteristics of tyrosine hydroxylation in isolated nerve endings. Biochem Pharmacol. 1976 Jan; 25(1):91-3. PMID: 3182.
    View in: PubMed
  634. Fischer JE, Baldessarini RJ. Letter: Neurotransmitter metabolism in hepatic encephalopathy. N Engl J Med. 1975 Nov 27; 293(22):1152-3. PMID: 241935.
    View in: PubMed
  635. Baldessarini RJ, Lipinski JF. Lithium salts: 1970-1975. Ann Intern Med. 1975 Oct; 83(4):527-33. PMID: 1166989.
    View in: PubMed
  636. Baldessarini RJ, Walton KG, Borgman RJ. Esters of apomorphine and N,N-dimethyldopamine as agonists of dopamine receptors in the rat brain in vivo. Neuropharmacology. 1975 Oct; 14(10):725-31. PMID: 1238952.
    View in: PubMed
  637. Baldessarini RJ. The basis for amine hypotheses in affective disorders. A critical evaluation. Arch Gen Psychiatry. 1975 Sep; 32(9):1087-93. PMID: 241308.
    View in: PubMed
  638. Baldessarini RJ, Amatruda TT, Griffith FF, Gerson S. Differential effects of serotonin on turning and sterotypy induced by apomorphine. Brain Res. 1975 Jul 25; 93(1):158-63. PMID: 124619.
    View in: PubMed
  639. Harris JE, Baldessarini RJ. Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum. Neuropharmacology. 1975 Jul; 14(7):457-71. PMID: 239367.
    View in: PubMed
  640. Baldessarini RJ. Editorial: Metabolic hypotheses in schizophrenia. N Engl J Med. 1975 Mar 06; 292(10):527-8. PMID: 1117895.
    View in: PubMed
  641. Harris JE, Baldessarini RJ, Morgenroth VH, Roth RH. Activation by cyclic 3':5'-adenosine monophosphate of tyrosine hydroxylase in the rat brain. Proc Natl Acad Sci U S A. 1975 Mar; 72(3):789-93. PMID: 236558; PMCID: PMC432405.
  642. Granacher RP, Baldessarini RJ. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry. 1975 Mar; 32(3):375-80. PMID: 1115577.
    View in: PubMed
  643. Baldessarini RJ. Biological transmethylation involving S-adenosylmethionine: development of assay methods and implications for neuropsychiatry. Int Rev Neurobiol. 1975; 18:41-67. PMID: 1107247.
    View in: PubMed
  644. Baldessarini RJ. Tardive dyskinesia: an evaluation of the etiologic association with neuroleptic therapy. Can Psychiatr Assoc J. 1974 Dec; 19(6):551-4. PMID: 4613452.
    View in: PubMed
  645. Harris JE, Morgenroth VH, Roth RH, Baldessarini RJ. Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP. Nature. 1974 Nov 08; 252(5479):156-8. PMID: 4153840.
    View in: PubMed
  646. Tarsy D, Baldessarini RJ. Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology. 1974 Nov; 13(10-11):927-40. PMID: 4474641.
    View in: PubMed
  647. Gerson S, Baldessarini RJ, Wheeler SC. Biochemical effects of dihydroxylated tryptamines on central indoleamine neurones. Neuropharmacology. 1974 Nov; 13(10-11):987-1004. PMID: 4280023.
    View in: PubMed
  648. Baldessarini RJ, Yorke C. Uptake and release of possible false transmitter amino acids by rat brain tissue. J Neurochem. 1974 Oct; 23(4):839-48. PMID: 4154359.
    View in: PubMed
  649. Baldessarini RJ, Lidz T. Letter: Comments on "an overview of schizophrenia". Am J Psychiatry. 1974 Sep; 131(9):1039-43. PMID: 4414152.
    View in: PubMed
  650. Jacobson G, Baldessarini RJ, Manschreck T. Tardive and withdrawal dyskinesia associated with haloperidol. Am J Psychiatry. 1974 Aug; 131(8):910-3. PMID: 4834709.
    View in: PubMed
  651. Baldessarini RJ, Harris JE. Effects of amphetamines on the metabolism of catecholamines in the rat brain. J Psychiatr Res. 1974; 11:41-3. PMID: 4477777.
    View in: PubMed
  652. Gerson S, Baldessarini RJ. Non-specific actions of dihydroxylated tryptamines in the central nervous system of the rat. J Pharm Pharmacol. 1974 Jan; 26(1):71-3. PMID: 4150942.
    View in: PubMed
  653. Tarsy D, Baldessarini RJ. Pharmacologically induced behavioural supersensitivity to apomorphine. Nat New Biol. 1973 Oct 31; 245(148):262-3. PMID: 4518989.
    View in: PubMed
  654. Lipinski J, Baldessarini R. Nonantipsychotic phenothiazines and tardive dyskinesia. N Engl J Med. 1973 Oct 04; 289(14):752. PMID: 4146969.
    View in: PubMed
  655. Baldessarini RJ, Fischer JE. Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation. Nat New Biol. 1973 Sep 05; 245(140):25-7. PMID: 4516938.
    View in: PubMed
  656. Harris JE, Baldessarini RJ. Letter: Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum. J Pharm Pharmacol. 1973 Sep; 25(9):755-7. PMID: 4148517.
    View in: PubMed
  657. Ebert MH, Baldessarini RJ, Lipinski JF, Berv K. Effects of electroconvulsive seizures on amine metabolism in the rat brain. Arch Gen Psychiatry. 1973 Sep; 29(3):397-401. PMID: 4724148.
    View in: PubMed
  658. Baldessarini RJ, Lipinski JF. Risks vs. benefits of antipsychotic drugs. N Engl J Med. 1973 Aug 23; 289(8):427-8. PMID: 4146359.
    View in: PubMed
  659. Harris JE, Baldessarini RJ. The uptake of (3H)dopamine by homogenates of rat corpus striatum: effects of cations. Life Sci. 1973 Aug 16; 13(4):303-12. PMID: 4127606.
    View in: PubMed
  660. Baldessarini RJ, Gerson S. Letter: Effects of 5,6-dihydroxytryptamine on the metabolism of 5-hydroxytryptamine in the central nervous system of the rat. J Pharm Pharmacol. 1973 Aug; 25(8):647-8. PMID: 4148434.
    View in: PubMed
  661. Harris JE, Baldessarini RJ. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology. 1973 Jul; 12(7):669-79. PMID: 4730376.
    View in: PubMed
  662. Lipinski JF, Schaumberg HH, Baldessarini RJ. Regional distribution of histamine in human brain. Brain Res. 1973 Mar 30; 52:403-8. PMID: 4700719.
    View in: PubMed
  663. Baldessarini RJ, Greiner E. Inhibition of catechol-O-methyl transferase by catechols and polyphenols. Biochem Pharmacol. 1973 Jan 15; 22(2):247-56. PMID: 4763253.
    View in: PubMed
  664. Baldessarini RJ, Karobath M. Biochemical physiology of central synapses. Annu Rev Physiol. 1973; 35:273-304. PMID: 4350615.
    View in: PubMed
  665. Baldessarini RJ, Karobath M. Effects of L-DOPA and L-3-O-methyl-DOPA on uptake of (3H)L-methionine by synaptosomes. Neuropharmacology. 1972 Sep; 11(5):715-20. PMID: 4670598.
    View in: PubMed
  666. Matthysse S, Baldessarini RJ, Vogt M. Methionine adenosyltransferase. A double-isotope derivative, enzymatic assay. Anal Biochem. 1972 Aug; 48(2):410-21. PMID: 5070040.
    View in: PubMed
  667. Baldessarini RJ. Symposium: behavior modification by drugs. I. Pharmacology of the amphetamines. Pediatrics. 1972 May; 49(5):694-701. PMID: 4338459.
    View in: PubMed
  668. Karobath M, Baldessarini RJ. Formation of catechol compounds from phenylalanine and tyrosine with isolated nerve endings. Nat New Biol. 1972 Apr 19; 236(68):206-8. PMID: 4622967.
    View in: PubMed
  669. Matthysse S, Baldessarini RJ. S-adenosylmethionine and catechol-O-methyl-transferase in schizophrenia. Am J Psychiatry. 1972 Apr; 128(10):1310-2. PMID: 5013751.
    View in: PubMed
  670. Baldessarini RJ. Interactions of drugs and amines in the brain. N Engl J Med. 1972 Mar 09; 286(10):542-3. PMID: 4333830.
    View in: PubMed
  671. Baldessarini RJ, Vogt M. Regional release of aromatic amines from tissues of the rat brain in vitro. J Neurochem. 1972 Mar; 19(3):755-61. PMID: 4555500.
    View in: PubMed
  672. Fischer JE, Snyder SH, James JH, Baldessarini R. Histamine and serotonin metabolism following massive small bowel resection. Ann Surg. 1972 Feb; 175(2):260-7. PMID: 4621790; PMCID: PMC1355137.
  673. Baldessarini RJ, Chace KV. Metabolism of L-dopa after inhibition of catechol-O-methyl transferase. Eur J Pharmacol. 1972 Jan; 17(1):163-6. PMID: 5016575.
    View in: PubMed
  674. Fischer JE, James JH, Baldessarini R. Changes in brain amines following portal flow diversion and acute hepatic coma: effects of levodopa (L-dopa) and intestinal sterilization. Surg Forum. 1972; 23(0):348-50. PMID: 4601328.
    View in: PubMed
  675. Baldessarini RJ, Lipinski JF, Chace KV. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat. Biochem Pharmacol. 1972 Jan; 21(1):77-87. PMID: 5058704.
    View in: PubMed
  676. Baldessarini RJ. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors. J Pharm Pharmacol. 1972 Jan; 24(1):78-80. PMID: 4401326.
    View in: PubMed
  677. Baldessarini RJ. Biogenic amines and behavior. Annu Rev Med. 1972; 23:343-54. PMID: 4577380.
    View in: PubMed
  678. Baldessarini RJ, Vogt M. The uptake and subcellular distribution of aromatic amines in the brain of the rat. J Neurochem. 1971 Dec; 18(12):2519-33. PMID: 4944459.
    View in: PubMed
  679. Baldessarini RJ. Release of aromatic amines from brain tissues of the rat in vitro. J Neurochem. 1971 Dec; 18(12):2509-18. PMID: 4944458.
    View in: PubMed
  680. Fischer JE, Baldessarini RJ. Renal changes in hepatic failure. Lancet. 1971 Oct 02; 2(7727):769-70. PMID: 4106260.
    View in: PubMed
  681. Baldessarini RJ. Compounds antagonistic to norepinephrine retention by rat brain homogenates. Biochem Pharmacol. 1971 Aug; 20(8):1769-80. PMID: 4944881.
    View in: PubMed
  682. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet. 1971 Jul 10; 2(7715):75-80. PMID: 4103986.
    View in: PubMed
  683. Baldessarini RJ, Vogt M. Uptake and release of norepinephrine by rat brain tissue fractions prepared by ultrafiltration. J Neurochem. 1971 Jun; 18(6):951-62. PMID: 5567914.
    View in: PubMed
  684. Chalmers JP, Baldessarini RJ, Wurtman RJ. Effects of L-dopa on norepinephrine metabolism in the brain. Proc Natl Acad Sci U S A. 1971 Mar; 68(3):662-6. PMID: 5276777; PMCID: PMC389012.
  685. Baldessarini RJ, Yorke C. Effects of lithium and of pH on synaptosomal metabolism of noradrenaline. Nature. 1970 Dec 26; 228(5278):1301-3. PMID: 5530657.
    View in: PubMed
  686. Baldessarini RJ. Frequency of diagnoses of schizophrenia versus affective disorders from 1944 to 1968. Am J Psychiatry. 1970 Dec; 127(6):759-63. PMID: 5482870.
    View in: PubMed
  687. Wurtman RJ, Matthysse S, Stephenson J, Baldessarini R. L-dihydroxyphenylalanine: effect on S-adenosylmethionine in brain. Science. 1970 Jul 24; 169(3943):395-7. PMID: 5450377.
    View in: PubMed
  688. Baldessarini RJ, Stephens JH. Lithium carbonate for affective disorders. I. Clinical pharmacology and toxicology. Arch Gen Psychiatry. 1970 Jan; 22(1):72-7. PMID: 5409523.
    View in: PubMed
  689. Baldessarini RJ, Willmuth RL. Psychotic reactions during amitriptyline therapy. Can Psychiatr Assoc J. 1968 Dec; 13(6):571-3. PMID: 5726841.
    View in: PubMed
  690. Baldessarini RJ, Kopin IJ. The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro. J Pharmacol Exp Ther. 1967 Apr; 156(1):31-8. PMID: 6023599.
    View in: PubMed
  691. Glowinski J, Baldessarini RJ. Metabolism of norepinephrine in the central nervous system. Pharmacol Rev. 1966 Dec; 18(4):1201-38. PMID: 4959625.
    View in: PubMed
  692. Snyder SH, Baldessarini RJ, Axelrod J. A sensitive and specific enzymatic isotopic assay for tissue histamine. J Pharmacol Exp Ther. 1966 Sep; 153(3):544-9. PMID: 5950817.
    View in: PubMed
  693. Baldessarini RJ, Kopin IJ. S-adenosylmethionine in brain and other tissues. J Neurochem. 1966 Aug; 13(8):769-77. PMID: 5911850.
    View in: PubMed
  694. Baldessarini RJ, Kopin IJ. Tritiated norepinephrine: release from brain slices by electrical stimulation. Science. 1966 Jun 17; 152(3729):1630-1. PMID: 4160809.
    View in: PubMed
  695. Baldessarini RJ. Alterations in tissue levels of S-adenosylmethionine. Biochem Pharmacol. 1966 Jun; 15(6):741-8. PMID: 4381472.
    View in: PubMed
  696. Fischer JE, Baldessarini RJ. Role of substrate supply in hepatic function following portacaval shunt. Surg Forum. 1966; 17:369-70. PMID: 5920966.
    View in: PubMed
  697. Baldessarini RJ, Bell WR. Methionine-activating enzyme and catechol-O-methyl transferase activity in normal and leukemic white blood cells. Nature. 1966 Jan 01; 209(5018):78-9. PMID: 5224275.
    View in: PubMed
  698. BALDESSARINI RJ. ADENOSYLMETHIONINE ELEVATION IN LEUKEMIC WHITE BLOOD CELLS. Science. 1965 Aug 06; 149(3684):644-5. PMID: 14331187.
    View in: PubMed
  699. Baldessarini RJ, Snyder SH. Schizophrenia. A critique of recent genetic-biochemical formulations. Nature. 1965 Jun 12; 206(989):1111-2. PMID: 5325442.
    View in: PubMed
  700. PARK LC, BALDESSARINI RJ, KETY SS. METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS. Arch Gen Psychiatry. 1965 Apr; 12:346-51. PMID: 14258360.
    View in: PubMed
  701. BALDESSARINI RJ, KOPIN IJ. ASSAY OF TISSUE LEVELS OF S-ADENOSYLMETHIONINE. Anal Biochem. 1963 Sep; 6:289-92. PMID: 14065930.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Baldessarini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (1171)
Explore
_
Co-Authors (71)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.